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A number of widely used industrial chemicals have been shown to possess 
endocrine-disrupting properties. In this thesis, a series of in vitro tests, and an in 
vivo reproductive performance test with fathead minnows, were used to clarify 
the extent of estrogenic activity exhibited by the phthalate esters - a class of 
compound hitherto referred to as 'estrogenic'. 
Using a recombinant yeast estrogen screen, I demonstrated that a small number 
of commercially available phthalates showed extremely weak estrogenic activity. 
The most potently estrogenic phthalate of those tested was BBP, which was 
approximately one million-fold less potent than 17B-estradiol. The phthalates 
which were estrogenic in the yeast screen were also mitogenic on estrogen-
responsive human breast cancer cells (MCF-7 and ZR-75 cell lines). The most 
prolifically used phthalate, DEHP, was not estrogenic in any of these assays. 
The small number of metabolites of phthalate metabolites tested (including 
MBuP, MBzP, MEHP and MnOP) were also not estrogenic in the recombinant 
yeast assay. 
The ability of BBP (as the most potently estrogenic phthalate in vitro) to induce a 
vitellogenic response (an indicator of estrogen exposure) in fathead minnows 
(Pimephales promelas) exposed via the water was assessed. No induction of 
vitellogenin was observed, indicating that 100 Jlg BBP/L (a concentration higher 
than would normally be found in the environment) is not estrogenic to this 
species of fish under the conditions employed for this experiment. In the same 
study, fecundity of breeding pairs of fathead minnows was assessed; exposure 
to BBP was not found to affect reproductive performance in these fish. 
A possible alternative mechanism of action of the way in which the phthalates 
induce frequently reported reproductive disorders was observed. Some of the 
phthalates, and, notably, some of their metabolites, were demonstrated to act as 
anti-androgens in a recombinant yeast androgen assay. 
4-Nonylphenol is another industrial chemical which is used in large volumes, 
and due to the nature of its use (mainly in detergent formulations), is discharged 
into water systems via sewage effluents. This chemical has been shown to be 
estrogenic to fish at the concentrations at which it has been detected in the 
environment. 
4-Nonylphenol was tested for its ability to affect plasma and pituitary 
gonadotropin levels in female recrudescing rainbow trout (Oncorhynchus 
mykiss). Plasma and pituitary levels of FSH were suppressed in fish exposed to 
10 and 100 Jlg 4-NP/L. In addition, FSH gene expression was reduced in these 
fish, and also in the fish exposed to 1 Jlg 4-NP/L. Pituitary LH content and gene 
expression of this hormone were suppressed in the fish exposed to 100-, and 
10- and 100 Jlg 4-NP/L respectively. Gonadal development in vertebrates is 
regulated by FSH. Ovarian development ceased in the fish exposed to 100 JAg 
4-NP/L, possibly as a result of the suppression of FSH synthesis and/or release 
in these fish. 
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CHAPTER 1 
INTRODUCTION 
1 
1.1 ENVIRONMENTAL ENDOCRINE DISRUPTION 
The issue of endocrine disrupters in environmental research is relatively young. 
One of the principal reasons for this is the subtlety of potential effects of such 
chemicals at the concentrations at which they are normally encountered in the 
environment, and therefore the length of time between the release of industrial 
chemicals and the realisation that their presence in the environment may be 
causing adverse effects in humans and/or wildlife. Indeed, it is possible that 
research efforts would have been even slower getting off the ground were it not 
for extreme exposure situations, culminating in distinct debilitating effects on 
humans or wildlife, such as when DES (diethylstilbestrol) was given to expectant 
mothers in the 1940's through to the 1970's (Stillman, 1982), and point source 
discharges or spills of highly toxic effluents into lakes and coastal areas (Guillette 
et ai, 1996; Anderson et ai, 1975). 
As a result of the youthfulness of this topic, there are presently few definitive 
statements which we can make about the effects of environmental endocrine 
disrupters on environmentally-exposed individuals. Limited data are available 
regarding the effects of some specific chemicals at the individual level in the 
laboratory. However, the big gap in our knowledge is in our understanding of the 
effects of endocrine disrupting chemicals, either singly or as mixtures, on wildlife 
(that is, wild animals, rather than laboratory animals) at the individual, let alone 
the population, level. There is a great deal of work to be undertaken before we 
can draw any conclusions as to the real threat of these chemicals to our 
ecosystems. 
1 .1 .1 Evidence for reproductive abnormalities in humans 
In recent years there appears to have been a striking increase in the incidences 
of reproductive disorders in humans, particularly in males. Abnormalities such as 
cryptorchidism, hypospadias, and testicular and prostate cancer are among the 
adverse reproductive health conditions occurring with increased frequency (as 
discussed by Toppari et ai, 1996). These cannot unequivocally be linked to the 
presence of endocrine disrupting chemicals (EDCs) in the environment; although 
their increasing incidence is correlated somewhat with a rise in exposure of the 
human population to industrial chemicals, the relationship hypothesised between 
the two is primarily by association. The majority of these disorders are thought to 
be related to malfunctions occurring during foetal development, and are similar to 
effects observed in the male offspring of DES-treated mothers (Gill et ai, 1979; 
Gill, 1989). It is also known that lipophilic organic chemicals can accumulate in 
body fat, and can be released during pregnancy (for example into placental fluid) 
as energy resources are exploited, thus increasing potential foetal exposure to 
EDCs. Thus, a plausible link between man-made organic chemicals and the 
apparent decrease in male reproductive health can be made, but evidence 
proving causality is not available presently. 
A possible reduction in sperm count, quality, and quantity, since the 1940's has 
also been discussed (Carlsen et ai, 1992; Auger et ai, 1995). While this too is not 
definitively a result of increased exposure to environmental estrogens - indeed 
these are controversial findings and they have been disputed on the basis of 
statistical inaccuracies (Olsen et ai, 1995) - Sharpe and Skakebaak (1993) 
hypothesised that the phenomenon may be linked to in utero exposure of 
humans to xenoestrogens. 
It is not only males which have appeared to show an increase in reproductive 
anomalies; there has also been a steady rise in the incidence of breast cancer in 
the past three or four decades (Wolff et ai, 1993). This too is a disease which in 
some cases can be enhanced by estrogens, and hence estrogen-mimicking 
chemicals could playa role in the aetiology of this disease. 
1.1.2 Evidence for reproductive abnormalities in wildlife 
There are a limited number of studies describing conclusive incidences of 
endocrine disruption in wild populations of any species. Certainly, there are few 
which can, beyond doubt, attribute effects at the level of the community to such 
contaminants. This is predominantly a result of the complex variety of 
environmental influences on wildlife ecosystems. Some of the studies attributing 
adverse reproductive effects in certain organisms to endocrine disrupting 
environmental pollutants - mainly as a result of accumulation of circumstantial 
evidence, but in some cases strengthened by similar effects observed in 
laboratory situations - are described below. 
3 
1.1.2.1 Mammals 
One of the earlier reports concerning population-level effects of what are now 
known to be, amongst other things, endocrine active pollutants, the 
polychlorinated biphenyls (PCBs), involved the collapsing number of common 
seals in one area of the Wadden Sea (the Netherlands) (Reijnders, 1986). It was 
known that PCB levels in seals inhabiting this area were elevated, and it was 
hypothesised that this may be affecting their reproductive capacity. Captive seals 
fed on fish from this area showed a higher rate of reproductive failure compared 
to control seals fed on uncontaminated fish, thus demonstrating an association 
between contaminants normally encountered by seals via their food source, and 
a physiological response in these mammals (Reijnders, 1986). 
More recently, the demise in number of the Florida Panther has been associated 
with reproductive impairment of this species as a result of exposure to toxicants 
such as p,p'-DDE and PCBs (Facemire et ai, 1995). Male panthers were found to 
contain E2 in their serum at concentrations similar to that observed in females, in 
addition to having low sperm counts and poor sperm quality, and incidences of 
cryptorchidism. 
Polar bears in Svalbard have also been reported to show signs of some kind of 
(androgenic) endocrine disruption, whereby a 1.5% incidence of 
"pseudohemaphroditism" - females exhibiting either a 20 mm penis (in addition 
to normal female genitalia), or clitoral hypertrophy - was observed (Wiig et ai, 
1998). This scenario is perhaps to be expected in Arctic and Antarctic regions if 
endocrine disruption is indeed a reality, since organic chemicals are known to 
migrate to and accumulate in colder environments (due to their lack of volatility at 
decreased temperatures), in addition to the fact that polar bears reside at the top 
of the food chain in these areas, consuming blubber-rich seals which themselves 
accumulate lipophilic pollutants. However, there were no indications of a 
population-level effect on the polar bears, and as yet no evidence of a lack of 
reproductive capacity of the pseudohermaphrodite females. 
1.1.2.2 Birds 
Some bird populations have shown evidence of declining numbers in relation to 
exposure to environmental contaminants. These have most frequently been fish-
eating species, feeding on fish inhabiting polluted waters, which are likely to 
accumulate toxic organic chemicals. However, some reports of birds affected by 
urban and agricultural pesticides, which may be acting via the endocrine system, 
have also been published (see Fry, 1995, for a review). One example is that of 
the Brown Pelican population on the Southern California coast. Up until 1970, a 
DDT manufacturing plant in the area discharged its waste into the ocean -
leading to contaminated fish stocks (eg anchovies) on which the pelicans fed -
and this was associated with falling pelican numbers. Around 1970, the plant 
changed its disposal practice, and deposited its waste into sanitary landfills. The 
subsequent improvement in eggshell condition and egg survival, culminating in 
an increased number of Brown Pelicans, was reported by Anderson et al (1975). 
Another fish-eating bird species, also present in Southern California, is the 
california gull (Larus californicus) , the embryos of which were reported to be 
feminised by DDT exposure (Fry & Toone, 1981). A controlled experiment was 
conducted by these scientists whereby gull eggs were injected with DDT at levels 
similar to those found in eggs of affected populations. This was found to induce 
adverse reproductive developmental effects on ovarian tissue, together with the 
production of oviducts in males. A link was suggested between these laboratory 
data and the observation of a skewed sex ratio (3.85:1 female:male) in the wild 
gull population (the eggs of which had been found to contain high concentrations 
of DDT), which in turn had led to female-female pairing at the nests of these 
birds. 
Reproductive failure in aquatic birds inhabiting the Great Lakes region has also 
been correlated to exposure to organic, halogenated compounds such as PCBs, 
PCDDs and PCDFs, which caused, in particular, eggshell thinning (Giesy et ai, 
1994). 
1.1.2.3 Reptiles 
The most extensively studied reptilian population thought to be exposed to 
endocrine disrupting chemicals is the alligators in Lake Apopka. Studies were 
initiated to assess the population status following a spill of DDT and dicofol into 
the lake, which is also contaminated by sewage and surrounded by an area of 
agricultural activity which may result in toxic runoff into the lake. A lack of 
recruitment of alligators in this lake was noted, and Guillette and colleagues have 
5 
followed up this finding with several studies in an attempt to pin down the 
reasons behind this reproductive failure. In 1994, they reported the existence of 
male alligators with decreased testosterone concentrations, abnormally 
developed testes, and small phalli. In addition, female alligators were found to 
have increased E2 levels and abnormal ovaries. It was suggested that the 
effects were due to exposure to toxic chemicals in ovo, and were irreversible 
(Guillette et ai, 1994). In unrelated studies, Rie et al (1999) have recently 
documented evidence of the negative impact of fuel and chemical spills on the 
reproductive system of the turtle. Although no evidence of excessive 
concentrations of organic pollutants in turtles was observed at the sites 
investigated, a mixture of contaminants was found, among them were some 
phthalates (thought to be weakly estrogenic, and recently also described as anti-
androgenic) (Rie et ai, 1999). 
1.1.2.4 Fish 
Clearly, if toxic organic chemicals are being discharged into aquatic systems, fish 
are a particularly vulnerable group of organisms. They have the potential to take 
up such toxins via several different pathways, and may be subject to 
bioconcentration of endocrine disrupters by virtue of the fact that they may be 
permanently surrounded by contaminated water. This water will pass over their 
gills, which are extremely efficient at removing chemicals from the water 
(particularly oxygen, of course). These chemicals enter the bloodstream, and 
reach most organs before passing through the liver (where they may be 
metabolized to less active chemicals). Fish may also receive exposure to 
toxicants through eating contaminated food, and since many fish species lie 
towards/at the top of the food chain, these chemicals may be found in relatively 
high concentrations in these organisms as a consequence of biomagnification. 
Much of the work undertaken regarding the estrogenic nature of sewage effluents 
discharged into rivers in England was initiated by a chance discovery. Scientists 
investigating vitellogenin levels (a yolk protein precursor, normally only found in 
mature female fish) in rainbow trout kept at a MAFF fish farm were surprised to 
find detectable concentrations of this substance in male fish. The discovery was 
thought to be a result of contamination by an estrogenic component in the treated 
sewage effluent which was present in the water in which the fish were kept 
(Sumpter, JP, pers. comm.). This discovery preceded a survey by these 
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scientists of effluents at various sewage treatment works (STWs) around the UK. 
Data from these studies, in which fish were kept for 3 weeks in treated effluent, 
indicated that each of the 15 effluents in which the fish survived (in 15 others all 
the fish died) induced the estrogenic response of vitellogenin production in the 
male rainbow trout (Purdom et ai, 1994). There was also a small amount of data 
in this paper describing the induction of this response downstream of the effluent 
discharge. The authors speculated that the chemical/s responsible may be 
ethynylestradiol, which is used in the contraceptive pill, and/or the alkylphenol 
ethoxylates used at that time in large quantities as surfactants in many products 
(eg detergents, pesticides). 
Subsequently, Harries et al (1997) extended the studies of Purdom et al (1994), 
and investigated the persistence of estrogenic activity downstream of effluent 
discharges from six STWs in England. In three of the rivers, no estrogenic effect 
was observed but at the other three, some element of estrogenicity was 
maintained (albeit at reduced potency) at up to 1.5 km, 4.5 km, and more than 5 
km downstream of the effluent discharges. Harries et al also studied the potency 
of various dilutions of effluent produced by Chelmsford and Harpenden STWs, 
and found that at dilutions of 25% and 50%, respectively, elevated plasma 
vitellogenin concentrations in male fish could be observed (Harries et ai, 1999). 
To put these data into context, many British rivers contain high concentrations of 
effluent; for example, the River Lea has been shown to comprise more than 80% 
effluent during the drier summer months (Harries et ai, 1999), and this figure is 
not atypical of many rivers in England. 
With respect to reproductive and potential populational effects in wild populations 
of fish in these rivers, Jobling et al recently reported high incidences of intersex 
roach inhabiting stretches of river downstream of STWs in England. This study 
was able to correlate the increasing frequency and degree of intersex with the 
concentration of sewage effluent at the various sites (as measured by population 
equivalents of the respective STWs and average annual dilution of the effluent) 
(Jobling et ai, 1998). Although the authors could not definitively state the sex of 
the intersex fish, it was suggested that they were feminised males as opposed to 
masculinised females, due to the number of "normal" males in a population being 
inversely proportional to the number of intersex fish. At some sites, 100% of 
macroscopic males were intersex to some degree. Although the impact of this 
finding on the successful reproduction and population endpoints is unknown 
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(studies are currently being undertaken to assess the reproductive capabilities of 
intersex fish), in general the phenomenon of intersex roach is thought to be rare. 
The first reported hermaphrodite roach was in 1909 (see Arme, 1965, for details), 
followed by the finding of one more individual specimen being reported by Arme 
(1965), and a microscopically intersex roach (1 out of more than 1000 specimens 
which had passed through the laboratory) was described by Jafri & Ensor (1979). 
The former two examples were macroscopic hermaphrodites (Le. intersexuality 
could be observed by eye, without the need for any microscopic investigation of 
the gonad) and the background information concerning microscopically intersex 
roach (whereby the gonad is not obviously intersex, but microscopic investigation 
shows that it is, by virtue of the fact that oocytes are found in the testes) is less 
prevalent. In 1981, Sweeting reported an unusually high incidence of 
hermaphrodite roach in the settlement lagoons of 2 STWs discharging into the 
river Lea, and, interestingly, found the highest proportion (up to 20%) in older 
fish, therefore leading to the hypothesis that a cumulative effect might be 
occurring (Sweeting, 1981). A follow-up survey by Ensor & Tinsley described the 
persistence of this condition in 6.4% of one of the populations of roach examined, 
compared to no intersex at all in the control fish (Ensor and Tinsley, 1984). 
In the US and Canada, although estrogenic sewage treatment effluents have 
been reported (Folmar et ai, 1996), they appear to be less of a issue in these 
countries, perhaps as a result of the higher level of treatment at STWs in the US, 
but also because, by virtue of the size of many American rivers, effluents are in 
any case diluted to a greater degree than in the UK. Research into the endocrine 
disruption of fish has focused more on discharges eschewing from pulp and 
paper mills. The endocrine disrupting nature of this type of effluent was first 
reported by Howell et al (1980), who reported the masculinization of female 
mosquitofish downstream of a paper mill discharge, as compared to the normal 
development of this species upstream of the outflow. This masculinization took 
the form of both physical secondary sex characteristics (females possessed an 
elongated anal fin, or gonopodium, which is used by males in the deposition of 
sperm), together with male reproductive behaviour. In addition, males exhibited 
signs of precocious development (Howell et ai, 1980). These effects were 
attributed to an androgenic component (of unknown nature) present in the 
effluent. Paper mill effluents such as these are known to contain phytoestrogens, 
for example B-sitosterol, and it has been suggested that these compounds may 
have been converted to androgenic compounds, thus rendering the effluent with 
8 
overriding masculinizing properties (Davis & Bortone, 1992). The initial study by 
Howell et al (1980) drew no conclusions as to the reproductive capabilities of the 
masculinized females, and it was, therefore, not possible to hypothesise as to 
potential population effects. More recently, Gagnon et al (1995) concluded that 
fish (in this case, white sucker) inhabiting stretches of river downstream of 
bleached kraft mill effluents invested less energy in reproduction, possessed 
smaller gonads, and exhibited an increased variability in fecundity, compared to 
uncontaminated rivers. 
1.1.2.5 Invertebrates 
A classic example of an unfolding story of endocrine disruption is the case of 
tributyl tin (TBT) inducing male characteristics in females of invertebrate 
populations. Smith first linked the occurrence of abnormal snails with pollution 
from marinas (Smith, 1981 a), which was followed by him reporting a relationship 
between these abnormalities and contamination from antifouling paint on ships 
hulls (Smith, 1981 b), after which this association was established by laboratory 
tests where imposex snails were produced following exposure to TBT (Smith, 
1981 c). In this latter report, there was apparently no impact on reproductive 
potential or population dynamics, and imposex was simply suggested to be a 
biological indicator of TBT contamination. However, certain invertebrate species 
(such as dog whelks) actually exhibited a reduction in numbers as a 
consequence of an imposex condition and the resultant inability to reproduce, 
and this was hypothesised as being a result of such organotin contamination 
(Spooner et ai, 1991). The mechanism behind this observed imposex effect is 
currently unclear, although it is thought to be a result of increasing androgen 
levels, due to the inhibition of aromatase activity by TBT, as opposed to a direct 
TBT effect (Spooner et ai, 1991; Bettin et ai, 1996). More recently, Ronis & 
Mason (1996) suggested that, in fact, TBT inhibits the sulphur conjugation and 
excretion of testosterone, which consequently leads to the increased androgen 
concentration in gastropod tissues. Whichever mechanism is correct (both could 
be, of course), the overall effect is increased testosterone concentrations, and 
hence masculinization of female molluscs. 
In summary, there are data available which suggest that adverse reproductive 
effects can be induced in wildlife by endocrine disrupting chemicals in 'natural ' 
environments, although the majority of sites examined have been subject to 
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profound pollution incidents, whether they be acute or chronic. Far less 
information is available regarding the long-term effects of lower concentrations of 
such chemicals on wildlife populations. 
1.2 GONADAL SEX STEROIDS 
1.2.1 Class, structure, and activity 
There are three main classes of sex steroids, the estrogens, androgens, and 
progestogens. They all have the same basic structure, consisting of four fused 
rings, with various oxygen and carbon substitutions conferring the properties of 
the individual steroids. Figure 1.1 shows this fused ring structure, along with the 
standard labelling of rings (A to D), and carbon positions (1 to 27), from which the 
steroid nomenclature is determined. Also shown here are estrane, androstane, 
and pregnane, which are the core structures of the estrogens, androgens, and 
progestogens, respectively. 
The synthesis of the steroid hormones is initiated by the conversion of acetate to 
cholesterol. This is the precursor of all steroid hormones. Cholesterol is 
transformed to pregnenolone, which is itself metabolised by a sequence of 
enzymes to form the steroids. A scheme depicting the pathway of steroid 
synthesis is shown in figure 1.2. Corticosteroids are also included in this 
schematic, but these are not considered sex steroids, and so will not feature in 
the following discussion. 
One aspect of steroid chemistry worth drawing attention to at this stage is 
conjugation. This involves the formation of an ester with sulphuric or glucuronic 
acid, thus making the steroid more soluble, together with deactivating it. In 
mammals, this process occurs in the liver, and is considered part of the excretory 
process (although some of the sulphate conjugates may be reconverted back to 
active compounds). In non-mammalian vertebrates, however, there may be 
alternative functions for these conjugated products. In the teleost testis, for 
example, the capacity for production of glucuronides is far higher than in the 
mammalian testis, and it has been suggested that since more glucuronides are 
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testosterone is converted via lIB-hydroxy testosterone to II-ketotestosterone. 
formed at higher temperatures, this may be a means of deactivating steroids, thus 
delaying reproductive processes until a more suitable environmental 
temperature is encountered (Scott, 1987). It is also thought that some of the 
steroid glucuronides act as pheromones; their enhanced solubility in water 
(compared to the non-conjugated steroids) would aid them in this role. 
A brief resume of the biological activity of the different steroid classes is 
presented in the following sections. 
1.2.1.1 Estrogens 
These are C18 steroids, the most important of which are 17B-estradiol (E2) and 
estrone (E1). They are considered the 'female' reproductive hormones, as they 
are secreted by the ovaries and are responsible for the control of sexual 
differentiation, secondary sex characteristics and the estrous cycle in mammals. 
In non-mammalian oviparous vertebrates, they playa crucial role in oocyte 
development, in that they induce the synthesis of vitellogenin. The production of 
estradiol in teleosts occurs via a 'two-cell' mechanism. Figure 1.3 shows a 
simplified diagram of an ovarian follicle. The outer 'theca' layer is stimulated by 
gonadotropins to produce androgens. These are then transported to the 
granulosa layer, where testosterone and androstenedione are aromatized to E2 
and E 1, respectively (via the enzyme P450 aromatase). 
1.2.1.2 Androgens 
The androgens are C 19 steroids, and are the 'male' reproductive hormones, 
being responsible for the development of male secondary sex characteristics and 
reproductive behaviour, along with stimulating spermiation. The most active 
androgens in mammals and teleosts are dihydrotestosterone and 11-
ketotestosterone, respectively. Similarly to the estrogens, these are synthesised 
in the gonads by a two cell mechanism, with testosterone being produced in the 
Leydig cells, and metabolised to the more active compounds in the Sertoli cells. 
Testosterone is also present in high concentrations in the female teleost. Indeed, 
it is often present at levels exceeding those found in males. However, the role of 
testosterone in the female is unclear, although it has been suggested that it may 
be concerned with the maintenance of oocyte maturation processes following 
vitellogenesis (Kime, 1993). 
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Schematic diagram of a teleost ovarian follicle, indicating the layers of the 
follicular wall where steroids are synthesised: androgens are produced 
in the theca layer, and following their move to the granulosa layer, are 
aromatised to estrogens. 
1.2.1.3 Progestogens 
These are C21 steroids. In mammals, progesterone is produced mainly by the 
ovaries, with minor secretions also by the testes and adrenal glands, and is 
primarily responsible for the maintenance of the placenta during pregnancy. In 
teleosts, the nature and role of progestogens differs, in that progesterone itself is 
of little consequence, but from this other progestogens, e.g. 17,20B-dihydroxy-4-
pregnen-3-one (17,20B-P) are synthesised, and these exert their influence over 
the final maturational stages of oocyte development, and also instigate germinal 
vesicle breakdown prior to spawning. 
Endocrine disruption to date has been predominantly concerned with the 
estrogens and androgens and their inhibitors, and thus the focus will rest on 
these for the remainder of this chapter. 
1.2.2 Activation of the receptor 
Steroid receptors are intended to be specific for a certain ligand. Once the 
steroid crosses the target cell membrane, it binds to a free receptor within the cell 
cytoplasm or nucleus; the binding of the ligand activates the receptor. The 
ligand-receptor complex then attaches to a specific regulatory site on the DNA, 
known as a 'response element' (RE). This step initiates transcription of genes 
which are regulated by the respective steroid, following which mRNA is 
transported to the cytoplasm and translated into the relevant protein (figure 1.4). 
It is thought that the RE is located upstream of different target genes in different 
cell types, thus accounting for the contrasting response of different cell types to 
the same steroid. 
The majority of reports regarding the estrogen receptor (ER) are concerned with 
what is now referred to as 'ERa'. Until recently, there was thought to be only one 
ER. However, in 1996, Kuiper et al reported the cloning of a second ER (referred 
to as 'ERB') from the rat prostate (Kuiper et ai, 1996), and subsequently an ERB 
has also been cloned in fish (the goldfish - Tchoudakova et ai, 1999). The 
implications of this discovery have yet to be fully determined, although it has 
been shown that the specific binding of E2 to ERa and ErB is of similar 
magnitude (Kuiper et ai, 1997), and it has also been demonstrated that 
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Schematic diagram illustrating the process of gene activation by steroid hormones. 
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xenoestrogens generally compete similarly with E2 for binding to the two 
receptors (Kuiper et ai, 1998). However, some phytoestrogens seem to have 
differing affinities for the ERa and ERB (Kuiper et ai, 1998), and the tissue 
distribution and expression of the two receptors in the rat also appears discrete. 
The continuing research into this aspect of endocrinology will no doubt enlighten 
us as to the possible differential functioning of the two receptors in the future. 
1.2.3 The role of sex steroid hormones in fish 
reproduction 
Sex determination in mammals and birds is controlled by genetic mechanisms, 
and in reptiles can be under the influence of temperature. In fish, the process of 
sex determination has not been fully elucidated, although here too, it is 
considered to be genetically controlled. However, the role of environmental and 
hormonal factors on phenotypic development is distinct in fish compared to that 
in mammals. Essentially, sexual differentiation in fish is considered plastic, and 
in the presence of estrogens the female phenotype will develop, whereas in the 
absence of estrogens the fish will develop male characteristics. Likewise, the 
presence of androgens at this early developmental stage results in the formation 
of the male phenotype. This situation can be artificially manipulated by the 
addition of pharmacological doses of hormones to the water during the labile 
period, just prior to sexual differentiation, which in salmonids occurs at the late 
pre-hatch to early juvenile stage (Piferrer and Donaldson, 1989). This is a 
practice undertaken by numerous commercial fish farms to produce single sex 
populations of fish. The resulting fish are phenotypically distinct as either males 
or females, and possess normal reproductive capabilities. With respect to 
environmental endocrine disrupters, the question is "what happens when early 
developmental stages are exposed to lesser concentrations of hormone 
mimics?" The phenotypic change may not be complete, leaving the exposed fish 
with intersex organs and unknown reproductive potential. This is the 
fundamental question currently being addressed in the freshwater fish, the roach, 
by Jobling and co-workers (e.g. Jobling et ai, 1998) the answer to which may 
provide us with some understanding of the potential effect of xenobiotic 
endocrine disrupters on the sustainability of wildlife communities. 
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In maturing fish, hormones can influence secondary sex characteristics and 
reproductive behaviour. In addition, estrogens are essential for oocyte 
development in females and androgens playa key role in spermatogenesis 
(estrogens have also been detected in male trout, although their function is 
unknown). More specifically, estrogens induce the production in the liver of 
vitellogenin, a large glycolipophosphoprotein, which is a precursor to egg yolk 
proteins. It is sequestered by developing oocytes before being broken down by 
the enzyme Cathepsin-D to yield the primary yolk proteins. Also crucial to 
successful oocyte development is the production of zona radiata (zr) proteins, 
which assist in the development of the eggshell, the production of which is 
stimulated by estrogens. Vitellogenesis in annual spawners such as the 
salmonids follows a distinct seasonal cycle, in which E2 concentrations cycle 
markedly (Scott and Sumpter, 1983). This rhythm of E2 accounts for the 
pronounced seasonal cycle of vitellogenin, and hence ovarian development. 
The E2 also plays a role, via feedback mechanisms, in the concentrations of 
gonadotropins (FSH and LH); these hormones also playa pivotal role in oocyte 
development and maturation, and their functions are discussed in greater detail 
in Chapter 4. The responsiveness of vitellogenin to estrogenic stimulation has 
culminated in the measurement of this protein in blood plasma as a biomarker for 
the presence of environmental estrogens, particularly in males or juvenile 
females (which are capable of generating this protein on stimulation with 
estrogens, but do not normally produce it due to the low endogenous levels of 
circulating estrogens). 
1.2.4 Occurrence of steroidal compounds in the aquatic 
environment 
Several studies have demonstrated the presence of hormones, both synthetic 
and natural, in watercourses and effluents in various countries. For example, 
Aherne and Briggs (1989) reported levels of ethinylestradiol (EE2) of up to 15 
ng/L in English rivers. Unusually, the effluents analysed in these studies were 
reported to contain lower concentrations of EE2 than the more dilute river water 
samples. However, this may have been a result of reduced recovery due to the 
high organic content of the effluent samples. This contrasts with the data of 
Stumpf et al (1996), who reported up to 62 ng EE2/L in effluents, but often were 
unable to detect this chemical in river water. In this case, E2 was present at 
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concentrations lower than EE2, of up to 20 ng/L in effluents. Ternes et al (1999) 
reported that EE2 was relatively persistent when in contact with activated sludge, 
whereas E2 was degraded. Presumably this also means that EE2 will be 
relatively persistent in the aquatic environment in general, and therefore may 
accumulate in a river which is constantly receiving contaminated sewage 
effluent. This may in part explain why Aherne and Briggs (1989) found higher 
concentrations in river water than in effluents, but does not explain why Stumpf et 
al (1996) were unable to detect EE2 in river water. Ternes et al (1999) also 
reported the important finding of the deconjugating ability of activated sludge, in 
that E2-glucuronides were shown to be metabolised in their experiments, 
releasing the active hormone. These data were supported by the observation of 
a vitellogenic response in male fathead minnows exposed to effluent from a 
simulated STW which had been dosed with E2-glucuronide. In contrast, fish 
administered E2-glucuronide directly, via a straghtforward flow-through system, 
exhibited no such estrogenic response (Panter et ai, 1999). 
Significant amounts of natural hormones may also be present in agricultural 
waste, following excretion by farm animals. Shore et al (1993) detected up to 
353 ng E2/L in agricultural sewage, and Nichols et al (1997) showed that E2 can 
be released from poultry litter, which is often applied to land as a fertiliser, 
therefore leading to agricultural runoff contaminated with naturally excreted 
hormones. 
Although the estrogenic activity of sewage effluents observed in the UK has been 
conjectured to be in part due to estrogens such as EE2, until recently this was 
speculation and it was not clear whether natural and/or synthetic hormones were 
present at concentrations sufficient to induce the estrogenic responses in fish, 
such as those observed by Harries at al (1997, 1999), and also whether they are 
the predominant estrogenic components of such effluents or whether there might 
be industrial or plant-derived estrogens contributing significantly to the 
estrogenic activity of these effluents. To address this issue, Desbrow et al (1998) 
used a toxicity identification and evaluation (TIE) approach, based on using an in 
vitro assay for estrogens (the recombinant yeast assay - as described in section 
2.1.1) to track the estrogenic activity during the fractionation of STW effluents, in 
an attempt to identify the main estrogenic chemicals in these effluents. The study 
focused on STWs receiving domestic, as opposed to industrial, waste, and found 
E2 and estrone (E1) to be present in each of the seven effluents studied, at 
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concentrations ranging from 1 to 50 ng/L and 1 to 80 ng/L, respectively. These 
hormones were the principal estrogenic components of these particular sewage 
effluents. EE2 was also detected in three out of the seven samples, albeit at 
lower concentrations than the natural hormones (0.2 to 7 ng/L). A subsequent 3 
week laboratory study demonstrated a statistically significant vitellogenic 
response in male rainbow trout exposed to 100 ng E2/L, and a response which 
was greater than, although not significantly different from, that observed in the 
control fish, in fish exposed to 10 ng E2/L (Routledge et ai, 1998). The authors 
also demonstrated that a combination of E2 and E1 induced a greater response 
than either hormone alone, and concluded that levels of estrogens found in the 
environment are capable of inducing vitellogenin production in fish. This report 
did not cover the response of fish to EE2, although an earlier study has 
suggested a no observed effect-concentration (NOEC) of 0.1 to 0.3 ng EE2/L 
(Sheahan et ai, 1994). It must be noted, however, that Desbrow et al (1998) 
based their conclusions on data from domestic effluents, and that the estrogenic 
components of industrial effluents, such as those encountered in the river Aire, 
may differ, although this has not yet been established. 
1.3 NA TURALL Y OCCURRING XENOESTROGENS IN THE 
ENVIRONMENT 
Probably the largest single class of xenoestrogens to which humans, and many 
wildlife species also, are exposed, are the phytoestrogens. This term covers a 
wide range of plant-derived compounds, and includes the flavonoids, the most 
prolific group of phytoestrogens, of which the isoflavones (e.g. genistein, 
daidzen), flavones (e.g. kaempferol), flavanones (e.g. naringenin), and the 
chalcones (e.g. phloretin) are sub-groups. Coumestrol is one of the most potent 
phytoestrogens, and is also a flavonoid-derived compound. Other groups of 
naturally occurring chemicals produced by plants (or fungi) which possess 
estrogenic members include the lignans (e.g. enterodiol, enterolactone), the 
mycoestrogens, which are of fungal origin (e.g. zearalenone), and the plant 
sterols (e.g. B-sitosterol). 
Since phytoestrogens are naturally occurring chemicals, humans and wildlife are 
exposed to them regularly via foodstuffs, as well as via their surroundings. 
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However, depending on the individual (or, in some cases, the population), 
phytoestrogen exposure of humans can be high, particularly if soy products form 
a major part of the diet. For example, soybeans and soyfoods have been 
reported to contain approximately 20,000 to 160,000 Ilg/100g dry weight of the 
isoflavones daidzen and genistein (Mazur and Adlercreutz, 1998). In the aquatic 
environment too, excessive concentrations of phytoestrogens can occur. Pulp 
and paper mill effluents are the most frequently reported contributors to 
phytoestrogen pollution. For example, total sterol concentration of pulp and 
paper mill effluents in the US was reported to range from 71 to 535 Ilg/L; the most 
prolific plant sterol detected in this study was B-sitosterol (Cook et ai, 1996). In 
Canada, bleached kraft mill effluent (BKME) was found to contain 1200 Ilg B-
sitosterol/L after primary treatment, and 280 I-lg B-sitosterol/L following secondary 
treatment (MacLatchy and van der Kraak, 1995). B-sitosterol has also been 
detected in effluent from domestic sewage treatment works in Germany, although 
at far lower concentrations compared to the pulp mill effluents; concentrations 
reported in STW effluents, river water, and tap water were up to 402 ng/L, up to 
56 ng/L, and 20 to 60 ng/L, respectively (Stumpf et ai, 1996). A further possible 
source of sterol contamination is waste from the fat industry (Protiva et ai, 1984), 
although data concerning concentrations in effluents from this origin are sparse, 
and the extent of pollution emanating from this source is unclear. 
Although the phytoestrogens are weakly estrogenic in comparison to the natural 
estrogens such as E2 and E 1 , they appear to be among the most potent 
xenoestrogens assayed in vitro, relative to other, synthetically produced, 
endocrine disrupting chemicals (Routledge and Sumpter, 1996; Gaido et ai, 
1997; Knudsen and Pottinger, 1999). This does not necessarily mean that this 
significant estrogenic activity would be translated to an in vivo situation, however, 
when factors such as metabolism, availability, and time of exposure, might all 
influence the enhanced I reduced activity of these chemicals in a whole animal. 
There might also be other mechanisms by which these chemicals can affect the 
endocrine systems of animals, such as inhibition of the activities of enzymes 
involved in the steroidogenic pathway. For example, some flavones are thought 
to inhibit P450 aromatase activity (Kellis and Vickery, 1984), and some 
phytoestrogens (including coumestrol and genistein) have been reported to 
inhibit the activity of 17B-hydroxysteroid oxidoreductase (Makela et ai, 1995), 
which catalyses the conversion of estrone to 17B-estradiol. MacLatchy and van 
der Kraak (1995) also reported reduced steroid synthesis in fish injected with B-
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sitosterol, which they attributed either to effects on available cholesterol levels or , 
on the activity of the side chain cleavage enzyme (P450scc), which may partially 
account for the reproductive disruption observed in fish exposed to this chemical 
via kraft mill effluents (discussed in section 1.1.2.5). However, not all authors 
agree that phytosterols are estrogenic. For example, whereas Mellanen et al 
(1996) reported B-sitosterol to induce estrogenic responses in vivo in rainbow 
trout, and in vitro in breast cancer cells, and an elevated plasma vitellogenin 
concentration was reported in fish exposed to this chemical by Tremblay and van 
der Kraak (1999), Baker et al (1999) concluded that the phytosterols were not 
estrogenic in either the in vitro or in vivo assays employed in their study. 
Phytoestrogens have been found to be responsible for various reproductive 
disorders in animal populations, such as infertility in captive cheetahs fed on a 
soybean-based diet (Setchell et ai, 1987). The best known example of adverse 
effects of phytoestrogens, however, is the so-called 'clover disease', which 
manifested itself in sheep of Western Australia way back in the 1940's (Bennetts 
et ai, 1946). The symptoms observed ranged from changes in external and 
internal reproductive organs, including cervical changes which led to reduced 
sperm breakthrough, mammary development in unmated ewes and wethers, and 
behavioural changes in ewes (Adams et ai, 1988; Adams, 1998). Essentially, a 
reduction in fertility, which impacted severely on lambing success, was the 
outcome. Extensive research in this area led to the conclusion that the amount of 
formononetin in the clover pastures was the influential factor in causing these 
disorders (Millington et ai, 1964), with this compound being metabolised to the 
estrogenic chemical, equol, in the rumen of the sheep (Cox and Braden, 1974). 
The subsequent cultivation of clover strains with lower formononetin 
concentrations has led to a reduced incidence of clinical outbreaks of clover 
disease, although subclinical infertility can still be a problem in sheep in this area 
of Australia. 
Despite these examples of adverse effects induced following exposure to 
naturally occurring phytoestrogens, it is considered by many that these 
compounds can actually playa protective role against certain hormone-related 
cancers (see Adlercreutz, 1995, for a review). Epidemiological studies have 
indicated (although it must be noted that they have not proven) a link between 
Western diets and an increased incidence of, particularly, breast cancer 
(Adlercreutz, 1990; Messina et ai, 1994), but also prostate cancer (Adlercreutz et 
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ai, 1993). Cell culture experiments using cancer cell lines suggest that certain 
phytoestrogens act as antiestrogens in that they inhibit the proliferation of these 
estrogen-dependent cells (Mousavi and Adlercreutz, 1993; So et ai, 1996; 
Peterson and Barnes, 1996). In vivo experiments have also illustrated the 
inhibition of carcinogen-induced tumours in rats by flavonoids and citrus juices 
(So et ai, 1996), although a recent article reported that in utero exposure of rats 
to genistein actually increased tumour incidence (Hilakavi-Clarke et ai, 1999). 
The mechanisms by which these compounds provide this apparent preventative 
effect are not clear, although it has been suggested that some of the 
phytoestrogens may stimulate the production of sex hormone binding globulin 
(SHBG), thus reducing the amount of available natural estrogens in the plasma 
(Adlercreutz, 1990; Mousavi and Adlercreutz, 1993). Whitten and Naftolin (1998) 
concluded that in vitro evidence suggests the process is more likely to involve 
receptor-mediated mechanisms than alterations to enzyme behaviour. In 
essence, there could be a multitude of pathways within and between particular 
groups of phytoestrogens by which they exert their endocrine disrupting effects, 
whether they are adverse or favourable. 
1.4 SYNTHETIC HORMONE MIMICS IN THE 
ENVIRONMENT 
Numerous industrial compounds have been found capable of eliciting hormone 
receptor-mediated responses in vitro. Many of these have also been associated 
with adverse reproductive effects in vivo in laboratory based studies. It is 
nevertheless likely that many environmental pollutants have not yet been 
identified as hormone mimics, and it is also possible that those which have been 
labelled 'environmental estrogens' can exert their effects via receptors or 
mechanisms other than solely the ER-mediated pathways. Some of the groups 
of industrial chemicals which are most widely accepted to behave as hormone 
mimics are discussed below. The bulk of the studies discussed are concerned 
with estrogenic activity as opposed to androgenic activity, and agonistic as 
opposed to antagonistic activity. One major reason for this focus on estrogenic 
chemicals is the widespread availability of both in vitro and in vivo assays for 
estrogens. There are currently fewer definitive endpoints available for 
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verification of androgenic and, particularly, anti-androgenic behaviour of 
chemicals, and hence the (possible) presence in the environment of chemicals 
with these activities is much less well studied. 
1.4.1 Organohalogen compounds 
1.4.1.1 Polychlorinated biphenyls 
The polychlorinated biphenyl's (PCBs) were first introduced into the commercial 
world in 1929, by the Monsanto Chemical Corporation, and are semi-volatile, 
persistent organic compounds, of which there are 209 different congeners. 
Some examples of PCB structures are shown in figure 1.5. Although the 
properties of individual congeners are dependent upon the number and 
positioning of the chlorine atoms, in general the PCBs are highly stable and inert, 
rendering them suitable for use in capacitors and transformers, as lubricants and 
plasticisers, as well as being employed to prevent the evaporation of pesticides 
following spraying. PCBs were first banned voluntarily in 1971, and legally in 
1979, but are still present in closed systems of old equipment. As a result of their 
resistance to chemical and thermal degradation, they are still one of the most 
ubiquitous environmental pollutants, and have been detected in samples far from 
any industrial influences, such as areas of the Arctic circle (Thomas et ai, 1992). 
Another consequence of the persistence and lipophilic nature of PCBs is the 
bioconcentration/biomagnification of these chemicals in organisms at various 
levels of the ecosystem (Evans et ai, 1991). These processes lead to increased 
body burdens of PCBs in top predator species, e.g. Narwhal in the Canadian 
Arctic (Muir et ai, 1992), and common seals in Northern Ireland (Mitchell and 
Kennedy, 1992), and also in their offspring. In mammals, for example, transfer of 
PCBs from mothers to young has been demonstrated to follow both uterine 
(Darnerud et ai, 1996) and lactational (Sinjari et ai, 1996) pathways, thus 
increasing the risk of exposure of young at sensitive developmental stages to 
highly toxic chemicals. An equivalent exposure situation may be encountered in 
non-mammalian vertebrates, whereby accumulation of PCBs has been observed 
in the ovaries of Atlantic croaker (Ungerer and Thomas, 1996), which may be due 
to the attraction of these lipophilic compounds to vitellogenin. Accumulation of 
such chemicals in the ovaries will, presumably, lead to deposition in eggs, and 
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hence exposure of larvae. PCBs have also been detected in the eggs of gulls 
(Pastor et ai, 1995a, 1995b). 
With respect to their hormonal activity, it appears that PCBs exert their effects 
through numerous mechanisms. Various PCB congeners have been 
demonstrated to induce estrogenic or anti-estrogenic effects in both in vitro and 
in vivo assays (Jansen et ai, 1993; Nesaretnum et ai, 1996; Nesaretnum and 
Darbre, 1997). Soto et al (1995) assayed 18 different congeners for estrogenic 
activity in the E-Screen, and concluded that out of these, 5 were estrogenic, none 
of which were coplanar (i.e. all of the estrogenic PCBs had substitutions at one or 
more ortho positions). Nonetheless, coplanar congeners can disrupt endocrine 
functions via alternative pathways (Safe at ai, 1985). Interaction with the aryl 
hydrocarbon receptor (AhR) is considered one of the key mechanisms of action 
of the PCBs (Safe et ai, 1985; Krishnan and Safe, 1993), together with the 
induction of the P 450 group of enzymes, which are responsible for metabolism of 
foreign chemicals. This action in itself may enhance the estrogenic activity of the 
PCBs, since their hydroxylated metabolites have been reported to be more active 
than the parent compounds (Soto et ai, 1995), thus in effect creating a cyclic 
'positive feedback' type of response. 
Laboratory studies have established the ability of aroclors (industrial mixtures of 
PCB's) to affect reproductive development of rats (Gellert, 1978) and to alter the 
sex ratio and gonadal development of rainbow trout (Matta et ai, 1998). 
Individual congeners have been reported to suppress maturation of female white 
perch (Monosson et ai, 1994), and to reverse the temperature-dependent sex 
determination of turtles (Bergeron et ai, 1994). A link with reproductive 
dysfunction in wild populations is more circumstantial; nonetheless, Murk et al 
(1996) observed a relationship between various reproductive endpoints (such as 
egg size and incubation period) and yolksac PCB content in a species of bird, the 
tern. Likewise, a correlation between whole egg PCB concentration and 
breeding success of cormorants in the Netherlands was reported by Dirksen et al 
(1995). Much research into PCB-contaminated freshwater sites has focused on 
the Great Lakes in the USA/Canada. Here, significant correlations have been 
found between PCB concentration and hatching success of lake trout inhabiting 
these waters. Knock-on effects have also been noted in fish-eating bird species 
in this area (Gilbertson et ai, 1991). 
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The mechanisms by which PCB's induce adverse reproductive effects in wildlife 
are certainly complex, but that such effects occur is unquestionable. 
1.4.1.2 Dioxins and furans 
The polychlorinated dibenzo-p-dioxins (PCDD's) and polychlorinated dibenzo-p-
furans (PCDF's) are similar in structure to the PCB's (see figure 1.5), and, like the 
PCB's, they are ubiquitous and persistent in the modern environment. However, 
they are not deliberately manufactured, but are by-products of incineration and 
manufacturing procedures. Dioxins have been detected at trace concentrations 
(parts per billion to parts per trillion) in environmental samples such as sewage 
(Hagenmaier et ai, 1992), in fish exposed to Kraft Mill effluent (Owens et ai, 
1994), in samples taken from landfill sites (Hansen and O'Keefe, 1996), and in 
drinking water (Lampi et ai, 1990). Their bioaccumulation factors in fish have 
been reported as ranging from 3000 to 106,000 (Frakes et ai, 1993), indicating 
the absence of metabolic potential of such organisms for these chemicals. The 
most toxic dioxin is 2,3,7,8-tetrachlorodibenzo-p-dioxin (frequently referred to as 
'TCDO'). Other related compounds are often given potency values relative to this 
chemical; these are known as Toxic Equivalency Factors (TEF's) (Safe et ai, 
1996). 
The dioxins and furans are essentially 'endocrine disrupters' rather than 
straightforward hormone mimics, since they can act on multiple elements of the 
endocrine system (Birnbaum, 1994). It has been known for several years that 
TCDO can cause infertility in rats (Gray and Kelce, 1996). Reproductive effects in 
male rodents exposed in utero to TCDD include delayed puberty, decreased 
sperm counts and epididymal sperm storage (Gray et ai, 1995); in females 
adverse effects include delayed puberty, decreased ovarian weight, and 
decreased fecundity (Gray and Ostby, 1995). TCDD has also been reported to 
inhibit estrone-induced implantation in hypophysectomised adult female rats 
(Johnson et ai, 1992). This chemical also caused diminished egg numbers and 
delayed oocyte development when administered to adult zebrafish 
(Wannemacher et ai, 1992). 
A review of the array of anti-estrogenic responses observed in organisms 
exposed to TCOD, along with activities of this chemical in in vitro systems, can be 
found in Safe et al (1991). However, it is thought that these effects are not 
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directly ER-mediated, but that these compounds are AhR ligands (Safe et ai, 
1991), although the precise mechanism behind the anti-estrogenic responses 
subsequent to the dioxins binding to the AhR are as yet unknown. 
1.4.2 Pesticides 
The potential for exposure of wildlife in general (and even humans) to pesticides 
may be higher than for many other synthetic chemicals, since these compounds 
are deliberately and prolifically released into the open environment, and applied 
directly to food crops throughout the world. The most prolific and toxic pesticides 
are of organochlorine structure, and along with their harmful nature, are lipophilic 
and therefore persistent in the environment and biomagnify up the food chain. 
Many of these organochlorine pesticides have been banned in developed 
countries (although they still persist in environmental samples), but may still be 
used in the developing world, where serious health issues such as malaria and 
other insect borne diseases are a major priority. Pesticides found capable of 
mimicking natural hormones (either in vitro or in vivo) include DDT, 
methoxychlor, endosulfan, dieldrin, lindane, kepone (chlordecane), and 
toxaphene (Soto et ai, 1995; Petit et ai, 1997). Vinclozolin (a fungicide) has also 
been implicated as an endocrine disrupter (Kelce et ai, 1994). 
One of the most widely researched organochlorine pesticides is DDT 
(dichlorodiphenyltrichloroethane). The commercial DDT mixture comprises 
different isomers, such as o,p'-DDT (15-20%), and p,p'-DDT (the predominant 
isomer). These compounds degrade to DDE and DDD, which may themselves 
possess hormonal characteristics. The presence of DDT in the environment has 
been associated with numerous adverse reproductive effects, primarily in wildlife, 
but also in humans. Although in vivo laboratory studies conducted as long ago 
as 1969 indicated the estrogenic nature of o,p'-DDT (Bitman et ai, 1969), reports 
of effects observed in exposed wildlife date back to the 1980's, where 
behavioural anomalies and skewed sex-ratio of gulls could be correlated to 
organochlorine pollution (Fry et ai, 1987), and DDT injected into eggs at 
concentrations similar to those found in wild birds eggs led to feminisation of the 
gonads in male chicks (Fry and Toone, 1981). Aquatic species have also been 
observed to possess reproductive abnormalities associated with DDT 
contamination. For example, Hose et al (1989) reported an exposed population 
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of white croaker to be exhibiting decreased fecundity and fertility, and delayed 
oocyte development compared to those sampled from a reference site; 
significantly decreased testosterone levels were measured in porpoises found to 
possess high levels of the DDT metabolite, DOE (Subramanian et ai, 1987); and 
a possible link between decreased penis size, along with lowered plasma 
testosterone concentrations, and elevated levels of p,p'-DDE in alligators 
inhabiting Lake Apopka was suggested by Guillette et al (1996). With respect to 
effects in humans, Wolff et al (1993) surveyed breast cancer patients and found 
that mean levels of DOE in such patients were significantly higher than in 
controls. However, subsequent studies have found no positive correlation 
between DDT levels and the risk of breast cancer (Safe, 1997). 
The endocrine activity of DDT and its metabolites in vitro is not straightforward. 
For example, o,p'-DDT is generally considered an estrogen receptor agonist, and 
has been reported as being estrogenically active in various in vitro assays 
(Donohoe and Curtis, 1996; Kelce et ai, 1995; Vonier et ai, 1996), but this isomer 
has also been found to be capable of binding to the AR, albeit with a lower affinity 
than to the ER (Kelce et ai, 1995). On the other hand, the major metabolite of 
DDT in humans, p,p'-DDE, has been found to be a relatively potent anti-
androgen (being approximately equipotent to hydroxyflutamide in inhibiting 
androgen-induced AR transcriptional activity) but also interacts (more weakly) 
with the ER (Kelce et ai, 1995). This situation, where a chemical can bind to 
more than one steroid receptor, may be quite common (Sohoni and Sumpter, 
1998). It would be unwise to try to predict from the results of these assays which 
pathway would generate the overriding effect in vivo. This illustrates the 
necessity for in vivo tests in this area of research, since metabolites might 
possess endocrine activity as well as their parent compounds, in addition to the 
possibility that these chemicals (both parent compounds and metabolites) may 
have multiple mechanisms of action. 
Another pesticide which may give misleading results if the parent compound 
alone is assessed for endocrine activity is methoxychlor. This was introduced as 
a DDT substitute, but has been demonstrated to induce estrogen-like responses 
in vivo (Welch et ai, 1969; Bitman and Cecil, 1970; Kupfer, 1975; Gray et ai, 
1988). However, the parent compound is not itself an ER agonist (Nelson, 1974; 
Bulger et ai, 1978a; Bulger et ai, 1978b). On investigation, Ousterhout et al 
(1981) discovered that the major metabolites of methoxychlor, these being the 
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mono- and bis-phenol derivatives, possessed significant estrogenic activity in an 
in vitro receptor binding study. There are two important messages from these 
data; on the one hand they warn against assessing the parent compound alone 
in vitro, since potential adverse effects of its derivatives may be overlooked and 
the chemical may incorrectly appear benign; on the other, these metabolites are 
more water soluble and therefore less likely to bioaccumulate than methoxychlor 
itself, and hence concentrations may not reach levels at which adverse effects 
would be manifest. 
Lindane is a pesticide which is most often available in its refined form (y-HCH), 
but which is sometimes produced as a commercial mixture, consisting of 3 main 
isomers, namely y-HCH, which confers the required insecticidal properties, (X-
HCH, the principal isomer at 60-70%, and a contaminant, B-HCH, which can be 
present in the mixture at 5-10%. The latter isomer is that which is considered an 
estrogen mimic, and is capable of inducing vitellogenin production in the guppy 
(Wester et ai, 1985), and testis ova in male medaka (Wester and Canton, 1986). 
However, y-HCH has also been demonstrated to disrupt reproductive processes 
in the zebrafish (Braunbeck et ai, 1990), and it affected steroid production in an in 
vitro study employing roach testes (Singh and Kime, 1995). More recently, 
lindane (y-HCH) was reported to decrease fecundity in mink exposed to the 
pesticide over 3 generations (Beard et ai, 1997). 
Results from the 'E-Screen', which employs an MCF-7 cell line to assess 
estrogenicity of chemicals, led Soto et al (1994) to conclude that each of the 
pesticides endosulfan, dieldrin, and toxaphene were weakly estrogenic. 
Endosulfan was observed to affect the reproductive behaviour of tropical fish, 
and delayed egg laying by the females, in a study performed by Matthiessen and 
Logan (1984). Although these effects did not definitively occur via an endocrine-
mediated pathway, mating behaviour can nonetheless influence survival of a 
population, and should not be overlooked. 
Another pesticide known to be estrogenic to both birds and mammals is kepone, 
also known as chlordecane (Palmiter and Mulvihill, 1978; Hammond et ai, 1979; 
Eroschenko and Palmiter, 1980), with decreased testicular and epididymal 
weight observed in hamsters administered this compound (Gray, 1982). 
Vinclozolin is a fungicide which is not as persistent as some of the 
organochlorine pesticides, but is metabolised to products (referred to as M 1 and 
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M2) which exhibit anti-androgenic activity (Kelce et ai, 1994), and gestational 
exposure of rats to the parent compound can generate various malformations in 
male offspring, with an overall effect of inhibition of sex differentiation (Gray et ai, 
1993). 
In general it must be noted that the use of many of the above-mentioned 
chemicals has diminished greatly, or even ceased, in the Western world. 
Nonetheless, due to their persistence, the fact that they are still in use in many 
developing countries, and their ability for biomagnification up the food chain, 
many of them still have the potential to reach concentrations in top predators 
which may affect their capacity to reproduce, particularly if more than one such 
endocrine disrupting chemical is present at once. From a human viewpoint, 
however, and certainly from that of a Westerner, exposure to organochlorine 
pesticides has been put into perspective by Gaido et al (1998), when they 
reported that a glass of wine possessed a higher estrogen equivalency rating 
than the daily consumption of estrogenic organochlorine pesticides via food, 
indicating that natural sources of estrogens may playa larger role in dietary 
estrogen intake than that played by pesticides. Clearly, however, this may not be 
the case in countries which continue to heavily employ such toxic compounds. 
Although not 'organochlorine' pesticides, the pyrethroids are perhaps more 
relevant to the endocrine-disrupting issue in the modern environment. These 
pesticides are in current, widespread usage throughout the world, and are used 
as ingredients in both agricultural and household products. A number of these 
pyrethroids, along with some of their derivatives (they are generally metabolised 
with relative rapidity in mammals, so the latter chemicals may be of high 
relevance with respect to their toxicity) were assessed for agonistic and 
antagonistic activity in recombinant yeast estrogen and androgen assays (Tyler 
et ai, 2000). Several of the parent compounds exhibited affinity for one or other 
of the receptors. Three metabolites of permethrin were also screened, of which 
one exhibited both estrogenic and anti-androgenic activity, and two were 
estrogen receptor antagonists. Data describing the possible endocrine 
disrupting behaviour of these pesticides in vivo is sparse, although they have 
been demonstrated to reduce fertility in rats administered high doses (Wauchope 
et ai, 1992). 
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1.4.3 Surfactants 
The principal class of surfactants known to be capable of inducing endocrine-
mediated responses in wildlife (primarily fish) are the alkylphenol 
polyethoxylates, or more specifically, their degradation products, the 
alkyl phenols. 
Briefly, although the estrogenic activity of the alkylphenols was reported as far 
back as 1938 (Dodds and Lawson, 1938), it appears that this information was not 
considered in the context of environmental pollution until Soto et al (1991) found 
nonylphenol (4-NP), which was leaching from laboratory equipment, to induce an 
estrogenic response in an MCF-7 cell line. Subsequent to this observation, 
numerous articles have identified the alkylphenols (the most common of which 
are octylphenol and nonylphenol) to be estrogenic in vitro (Jobling and Sumpter, 
1993; White et ai, 1994; Routledge and Sumpter, 1996; Celius et ai, 1999; 
Cold ham et ai, 1997; Gaido et ai, 1997), and in vivo (Jobling et ai, 1996; Lech et 
ai, 1996; Christiansen et ai, 1999; Pedersen et ai, 1999; Yadetie et ai, 1999; 
Arukwe et ai, 1997; Milligan et ai, 1998). 
Concern over the potential toxicity of these compounds as a result of their 
endocrine activity has culminated in the phasing out of the alkylphenol 
ethoxylates in domestic applications (e.g. ENDS, 1997), and more recently, there 
have been moves toward a more widespread ban covering industrial and 
agricultural applications also (ENDS, 1999a). 
A more comprehensive discussion of the alkyl phenols can be found in chapter 4 
(section 4.1.1). 
1.4.4 Plasticisers and other plastics components 
The phthalates are one of the most widely employed classes of endocrine-
disrupting compounds in current usage. Once again, a more comprehensive 
discussion of their occurrence in the general environment, and hormone-
mimicking behaviour, is provided in chapter 3. In summary, these chemicals 
should not be considered collectively as 'estrogen mimics'. Some of the 
phthalates show weak estrogenic activity in in vitro assays (Jobling et ai, 1995; 
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Soto et ai, 1995; Petit et ai, 1997; Cold ham et ai, 1997; Harris et ai, 1997; 
Zacharewski et ai, 1998}, but some are inactive in these assays. So far, 
however, despite numerous reports indicating the reproductive toxicity of certain 
phthalates, studies demonstrating specific endocrine-mediated responses of 
these chemicals have proven inconclusive. More recently, the possibility that 
some of the phthalates may act as anti-androgens has been raised (Sohoni and 
Sumpter, 1998; Mylchreest at ai, 1998), although the mechanisms involved in the 
induction of the effects observed by Mylchreest et al have not yet been elucidated 
(Mylchreest et ai, 1999). 
Another chemical frequently used as an ingredient in plastic formulations, most 
prolifically as a monomer for polycarbonates, but also in epoxy resins, and which 
has been detected in leachate from dental resins (Olea et ai, 1996) and lacquer 
coatings in food cans (Srotons et ai, 1995), is Sisphenol-A (SPA). As with the 
phthalates, hundreds of thousands of tonnes of SPA are produced per annum in 
Europe alone. 
Similar to the scenario with NP, the estrogenic activity of SPA was stumbled upon 
when it leached from laboratory equipment (polycarbonate flasks) into medium 
which subsequently induced proliferation of MCF-7 cells in an estrogen-
dependent manner (Krishnan et ai, 1993). It was subsequently reported as being 
approximately 1000 times less potent than E2 in a recombinant yeast estrogen 
assay (Routledge and Sumpter, 1996). Primary hepatocytes of fish incubated in 
a medium containing SPA produced zona radiata proteins and/or vitellogenin, 
both of which are estrogen-dependent responses (Sumpter and Jobling, 1995; 
Celius et ai, 1999; Smeets et ai, 1999a, 1999b). Further studies with breast 
cancer cell lines have also confirmed the mitogenic properties of this chemical 
(Soto et ai, 1995; Schafer et ai, 1999). The effect of the presence of serum on the 
in vitro potency of SPA was investigated by Nagel et al (1997), and it was 
demonstrated that serum enhanced the potency of this chemical relative to E2, 
and also to OP, in MCF-7 cell lines. These results were also reflected in vivo, 
whereby SPA appeared to affect reproductive development in exposed rats at 
lower doses than OP (Nagel et ai, 1997). Induction of VTG mRNA in primary 
hepatocytes of male amphibia, Xenopus laevis, was enhanced by the presence 
of SPA, and in the same species in vivo administration of this chemical during 
larval development altered the sex ratio of treated groups relative to the controls 
(with increased numbers of females ensuing) (Kloas et ai, 1999). In fish also, 
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BPA has been demonstrated to induce VTG production in rainbow trout 
(Christiansen et ai, 1998). In contrast, Nagao et al (1999) reported normal 
reproductive development of rats treated postnatally with BPA. It may be that the 
timing of exposure is the crucial factor in inducing reproductive abnormalities in 
such experiments, although too few studies have been published to state this 
conclusively. 
1.5 AIMS 
The aims of this project were essentially two-fold. The first was to investigate the 
potential estrogenic activity of individual phthalates. Prior to this study, there 
were very limited data available on the endocrine activities of these chemicals 
(e.g. Jobling et ai, 1995), and their very extensive use led to this work being 
considered a high priority. The second aim was to determine if endocrine active 
chemicals could exert effects at higher centres of the axis controlling 
reproduction (specifically, the brain); that is, extend the findings that endocrine 
disrupters can affect the gonad and liver (at least of oviparous vertebrates) to 
determine whether they can also affect higher levels of the brain-pituitary-
gonadal (BPG) axis. 
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CHAPTER 2 
GENERAL MATERIALS AND METHODS 
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2.1 METHODS EMPLOYED IN THE ASSESSMENT OF 
THE ENDOCRINE DISRUPTING POTENTIAL OF 
CHEMICALS 
Methods of determining the endocrine activities of chemicals can essentially be 
split into two categories: in vitro and in vivo. Each has its own distinct 
advantages; for example, in vitro assays are quicker, more economical, and 
generally highly specific, whereas in vivo assays provide us with a more realistic 
idea of how the chemical may behave in a whole animal, by taking into account 
factors such as metabolism, which may create or negate the activity of a 
chemical. 
Opinions on the benefits of available in vitro assays vary (Zacharewski, 1997). 
Probably the best approach would be to employ a battery of different in vitro 
assays, followed by confirmation of any positive results using in vivo assays 
(Gray, 1998). It must be noted that it is also important to include in in vitro tests 
metabolites of chemicals which are known to be found in the environment or in 
wildlife or humans, in an attempt to avoid "false negative" responses. 
In vitro assays for EDCs currently in use include mammalian cell lines, for 
example breast cancer cell lines, which are stimulated to proliferate by 
estrogens, or prostate cancer cell lines which respond to androgens; 
recombinant yeasts, which have been genetically modified to incorporate a gene 
for a steroid receptor (either estrogen or androgen); receptor binding assays, 
which are based on the competition between a radiolabelled ligand and an 
unlabelled ligand for binding to a steroid receptor; and the less frequently used 
fish hepatocyte cultures, which produce the egg yolk protein vitellogenin in 
response to estrogeniC chemicals. 
The most widely employed mammalian in vivo assay with a specifically estrogen-
regulated endpoint is the rodent uterotrophic assay. In this assay, immature 
female rats are administered the test chemical, and their uteri weighed 3-5 days 
later. An estrogenic substance stimulates an increase in weight of the uterus 
(Hisaw, 1959). This assay is also useful in that it can be used to detect anti-
estrogens (Wakeling and Valcaccia, 1983). However, despite providing more 
realistic data with respect to the behaviour of chemicals in a whole animal, the 
uterotrophic assay is nonetheless short-term, and may not be sensitive enough to 
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detect weakly estrogenic chemicals (Zacharewski, 1998). In fish, the induction of 
vitellogenin production is one of the most sensitive and easily assessed 
indicators of estrogenic exposure (Sumpter and Jobling, 1995). This is 
especially true in male or juvenile female fish, since endogenous levels of this 
protein are extremely low. In this thesis, a variety of in vitro and in vivo assays 
were used to detect and quantify the endocrine disrupting potential of chemicals. 
The basic methodology employed in these assays is described below; in 
subsequent chapters, specific details relevant to the particular objective being 
investigated are included. 
2.1.1 Recombinant yeast assays 
The recombinant yeast screen was the most extensively utilised assay for 
detection of endocrine activity in this thesis. This is in part due to it's 
straightforward procedure, whereby the assay is performed in 96-well microtitre 
plates, thus allowing a wide range of concentrations of a test chemical to be 
tested in each assay; it is also both time- and cost-efficient; finally, the assay is 
highly reproducible, specific, and sensitive (Routledge and Sumpter, 1996). 
Two different strains of recombinant yeast were used in the studies performed in 
this thesis, one of which contained the hERa gene, and the other the hAR gene. 
These strains were developed by Glaxo-Wellcome (Purvis et ai, 1991) and the 
assays were later validated by Routledge and Sumpter, 1996 (the estrogen 
assay), and Sohoni and Sumpter, 1998 (the androgen assay). Essentially, the 
hER gene (now known as ERa, to distinguish it from the more recently 
discovered ERB), or the hAR gene, have been integrated into the main genome 
of the yeast. The yeasts also contain an expression plasmid, consisting of a 
response element (RE), a promoter gene, and the Lac-Z gene - which codes for 
the enzyme B-galactosidase. The hER (or hAR) is expressed in a form capable of 
binding to the RE; once activated by a bound ligand, expression of Lac-Z is 
triggered, resulting in the production of B-galactosidase. This enzyme is a hybrid 
form, possessing a peptide leader sequence, enabling it to pass across the cell 
wall of the yeast into the surrounding medium, where it metabolises the 
chromogenic substance CPRG (chlorophenol-red-B-D-galactopyranoside), 
causing a colour change from yellow to red. This colour change can be 
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monitored by eye, or measured quantitatively using a spectrophotometer. A 
simplified diagram of the yeast make-up is shown in figure 2.1. 
2.1.1.1 Preparation and storage of medium components 
All glassware was thoroughly solvent washed before use. Any glassware which 
had come into contact with steroids or known xenobiotic endocrine disrupters 
was first rinsed in 20% HCI. 
The minimal medium was prepared by adding 13.61 9 KH2P04, 1.98 9 
(NH4hS04, 4.2 9 KOH pellets, 0.2 9 MgS04, 1 ml Fe2(S04h solution (40 mg/50 ml 
H20), 50 mg L-Ieucine, 50 mg L-histidine, 50 mg adenine, 20 mg L-argenine-HCI, 
20 mg L-methionine, 30 mg L-tyrosine, 30 mg L-isoleucine, 30 mg L-Iysine-HCI, 
25 mg L-phenylalanine, 100 mg L-glutamic acid, 150 mg L-valine, and 375 mg L-
serine to 1 litre double-distilled water. The solution was aliquotted into 45 ml 
portions, sterilised at 121 DC for 10 minutes, and stored at room temperature. 
Vitamin solution was prepared by adding 8 mg thiamine, 8 mg pyridoxine, 8 mg 
pantothenic acid, 40 mg inositol, and 20 ml biotin solution (2 mg/100 ml H20) to 
180 ml double distilled water. The solution was sterilised by filtering through a 
0.2 Jlm pore size disposable filter, into sterile bottles in 10 ml aliquots. The 
solution was stored at 4DC. 
A 20% w/v glucose solution was prepared, which was sterilised at 121 DC for 10 
minutes, and stored at room temperature. 
Solutions of 4 mg/ml L-aspartic acid, and 24 mg/ml L-threonine were made, also 
sterilised at 121 DC for 10 minutes, and stored at room temperature. 
A copper (II) sulphate solution (20 mM) was filter sterilised through a 0.2 Jlm 
pore-size filter into sterile glass bottles and stored at room temperature. A 
solution of 10 mg/ml chlorophenol-red-B-D-galactopyranoside (CPRG) was 
sterilised in the same way, and stored at 4DC. 
Growth medium consisted of 45 ml minimal medium,S ml glucose solution, 1.25 
ml L-aspartic acid solution, 0.5 ml vitamin solution, 0.4 ml L-threonine solution, 
and 125 JlI copper (II) sulphate solution. 
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Schematic diagram of the estrogen inducible expression system in yeast. 
Acti vation of the estrogen receptor, by binding of ligand, enables the complex 
to bind to estrogen response elements (ERE) on the expression plasmid. 
This causes expression of the reporter gene Lac-Z, which produces the enzyme 
B-galactosidase. This enzyme passes into the medium, and metabolises the 
chromogenic substrate, CPRG, into a red substance. 
(Adapted from Routledge and Sumpter, 1996). 
10 times concentrated yeast stocks were stored in minimal medium (with 150/0 
glycerol) at -20°C. 
2.1.1.2 Assay procedure 
All work involving recombinant yeast was carried out in a type II laminar flow 
cabinet. A 24 hour yeast culture was prepared, by adding 125 ~I of 10 times 
concentrated yeast stock to 50 ml growth medium in a sterile conical flask. The 
culture was incubated at 28°C for approximately 24 hours on an orbital shaker. 
The assay medium was then prepared by seeding 50 ml fresh growth medium 
with 4x1 07 yeast cells from the 24 hr culture, and adding 0.5 ml CPRG to the 
medium. 
Chemicals were serially diluted in the solvent in which they were stored (usually 
ethanol). 1 0 ~I volumes of each dilution were transferred into a 96 well optically 
flat bottom microtitre plate (Linbro/Titertek, ICN FLOW, Bucks, UK). 1 0 ~I ethanol 
(or appropriate solvent) was added to blank wells (one row in each plate). The 
ethanol was evaporated to dryness. 200 ~I of assay medium was added to each 
well using a multichannel pipette. At least one standard curve of an appropriate 
positive control (e.g. E2 in the estrogen assay) was included in each assay. The 
plates were sealed with autoclave tape (to prevent excessive evaporation of 
water from the medium), and shaken vigorously for 2 minutes on a microtitre 
plate shaker. The plates were incubated at 32°C in a naturally ventilated oven 
(WTB binder, BO-series, Jencons Scientific Ltd., Beds, UK). 
Plates were shaken after 24 hours incubation, to disperse the growing yeast 
cells, and absorbance monitored after 3 to 6 days incubation. Absorbance 
readings at 540 nm and 620 nm were taken after 3 days incubation (using a 
Titertek Multiskan MCC/340 plate reader, Life Sciences Int., Basingstoke, UK) 
after which the plates were removed from the incubator and left at room 
temperature. Assays conducted using weakly estrogenic chemicals (such as the 
phthalates) were monitored over the subsequent days, and absorbance readings 
were taken once more 6 days after the assay had been set up. Assays set up 
using the androgen responsive yeast were incubated for 24 hours only at 32°C, 
after which they were incubated at 28°C for a further 24 hours, then removed 
from the incubator and left at room temperature until the plates were read (3 days 
after setting up the assay). 
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The absorbance readings at 540 nm (which measures the redness in the 
medium) were corrected for turbidity (absorbance at 620 nm) using the following 
calculation: 
Corrected value = chemical absorbance (540 nm) - [chemical absorbance 
(620 nm) - blank absorbance (620 nm)]. 
2.1.1.3 Specificity and sensitivity 
The yeast estrogen assay is highly specific for estrogens; androgens, 
progesterones and corticosteroids are either completely inactive or very weakly 
active at very high concentrations. The activities of some of these steroids in the 
estrogen screen are shown in figure 2.2 (adapted from Routledge and Sumpter, 
1996). E2 was assayed at concentrations ranging from 1 x1 0-8 M to 4.8x1 0-12 M. 
A concentration as low as 2 ng/L (7.35X1 0-12 M) induced a detectable increase in 
B-galactosidase production after a 3-day incubation period. 
In contrast, the androgen screen, validated by Sohoni and Sumpter (1998), is 
both less specific and less sensitive. The latter observation is mainly due to the 
fact that it was developed earlier than the estrogen screen, and sensitivity of the 
assay had not been optimised. Figure 2.3 (as published in Sohoni and Sumpter, 
1998) illustrates the activities of steroids in the androgen screen. DHT 
(dihydrotestosterone) and testosterone were approximately equipotent, the 
minimum detectable concentrations were approximately 4x1 0-10 M (Sohoni and 
Sumpter 1998). In this assay, however, E2 appeared to be able to cross-react 
with the androgen receptor, and was approximately 15-fold less potent than DHT 
and testosterone (put another way, E2 had approximately 6% of the binding 
potental of these androgens). It seems possible from these data that the AR is, in 
fact, intrinsically less specific that the ER. Evidence for this hypothesis was first 
demonstrated by Wilson and French (1976), who found that the AR showed 
about 3 to 4% cross-reaction with estrogens; in 1997, Gaido et al also published 
data indicating that E2 had approximately 4% the potency of DHT, and 5.50/0 the 
potency of testosterone, in their yeast-based assay (Gaido et ai, 1997). The 
reduced specificity of this androgen assay, compared to the estrogen assay, may 
therefore be a function of the general promiscuity of the AR, and is obviously not 
restricted to this particular strain of yeast. 
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Figure 2.2 
Specificity of the recombinant yeast estrogen assay to 
(A) Estrogens, and (B) Androgens, progesterones and 
corticosteroids (adapted from Routledge & Sumpter, 1996). 
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The specificity of the recombinant yeast androgen assay. 
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2.1.1.4 Calculation of potencies of test chemicals 
The potencies of chemicals tested can be compared to that of the relevant steroid 
by extrapolating from the standard curve at 50% of the maximum response. The 
concentrations of the test chemical and the standard at this absorbance were 
read from the graph, as illustrated in figure 2.4. The potency of the chemical can 
be calculated by either of the following equations: ED50(test chemical) / 
ED50(standard); or the inverse of this. The former describes the factor by which 
the chemical is less potent than the standard in the screen, and the latter 
expresses this value as a fraction. Where the maximum response did not 
actually reach 50%, as was the case with many of the estrogenically-active 
phthalates, the same calculation was carried out at 25% response, and if this was 
not possible, the response was simply described as greater than that of the 
control. 
2.1.2 Mammalian breast cancer cell lines 
Estrogen responsive human breast cancer cell lines were used to confirm any 
estrogenic activity of the major volume use phthalates that was observed in the 
yeast screen. It was considered that in the case of the phthalates, cells of human 
origin may be of particular relevance in assessing activity, since human exposure 
to these chemicals is potentially extensive. The MCF-7 cell line, in particular, has 
been demonstrated to be responsive to estrogens by its estrogen dependency to 
grow as a tumour in athymic mice (Soule and McGrath, 1980; Soto and 
Sonnenschein, 1985) and was developed as a bioassay to detect estrogenic 
xenobiotics by Soto et al (1992). This type of cell line has since been reported as 
a screen which can be used to identify the estrogenic activity of environmental 
chemicals (e.g. Sonnenschein et ai, 1995; Klotz et al 1996). 
2.1.2.1 Assay procedure 
Cells were cultured in phenol red-free medium containing 5% v/v charcoal 
dextran stripped serum (DCC). Cells were plated in 6 well plates (Falcon, Becton 
Dickinson, Lincoln Park, NJ) into this medium 3 to 4 days prior to the experiment. 
Two experimental designs were used. The first investigated the ability of the 
chemical to induce proliferation of the cells over time, and involved replacing 
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Figure 2.4 
An illustration of how the potency of a chemical compared to that of 
E2 can be calculated. In this case, the ED50 of E2 is approximately 
8x10-11 M, at an absorbance (at 540 nm) of 1.7. A concentration of 
8x 10-6 M of test chemical is required to produce the same magnitude 
of response. This chemical is therefore 8x10-6 / 8x10-11 (=100,000) 
times less potent than E2. Put another way, the chemical induces a 
response which is 0.00001 times that induced by E2. 
medium with treated medium containing either 0.1 % vehicle solvent (ethanol), 
10-
8 M E2, or 10-5 M of test chemical. Treatments were applied in duplicate. 
Medium was renewed every 3 days, and cells were trypsinized and counted 
using a Coulter Counter after 0, 2, 5, 8, and 12 days of incubation. The second 
design tested the response of the cells to varying doses of test chemical. In these 
experiments, treated medium contained vehicle solvent, 10-8 M, 10-10 M, and 10-12 
M E2, or 10-5 M, 10-6 M, and 10-7 M test chemical. Treatments were in triplicate, 
medium was renewed every 3 days, and cells were counted at a single endpoint 
after 11 days incubation. 
2.2 THE RADIOIMMUNOASSA Y 
The principle of a radioimmunoassay is based upon the equal competition 
between a radiolabelled ligand and an unlabelled ligand for binding to a specific 
antibody. The amount of radiolabelled ligand and the amount of antibody used 
in an assay are kept constant, such that when the mixture of reagents has been 
allowed to reach equilibrium, the amount of radiolabelled ligand which is bound 
to the antibody will be dependent upon (and inversely proportional to) the 
amount of unlabelled ligand in the mixture. The maximum amount of label which 
can bind to the antibody (Maximum Binding, or IMBI) is determined by incubating 
without any standard or unknown sample. Small amounts of label will also 
behave as bound ligand, even in the absence of antibody; this is known as non-
specific binding (NSB). Reasons for this include factors such as binding of the 
label to other assay components, trapping of label in the bound complex, 
presence of impurities in the label, absorption of free tracer to the reaction tube, 
or the incomplete aspiration of the unbound fraction from the tube. These values, 
MB and NSB, essentially represent the upper and lower limits of the assay. 
2.2.1 The standard curve 
With each assay, a standard curve is included in order to determine the 
concentration range over which the amount of unknown ligand can be quantified. 
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The assay is set up with fixed amounts of antibody and label, but with serially 
diluted concentrations of a known amount of unlabelled standard. The NSB 
value is subtracted from the MB value, and the corrected MB is taken as 100% • 
The remaining values for the standard tubes are also corrected for NSB and are 
expressed as a percentage of MB. The data are plotted on a logarithmic scale 
and a sigmoidal curve is produced. At the lower end of the curve (where high 
concentrations of standard are present), the competition is strongly in favour of 
the standard, and hence relatively little label binds. At the upper end, there is 
relatively little standard, and hence the competition is strongly in favour of the 
label (and so much of the antibody binds to the label). The central region of the 
curve is that over which we can extrapolate sample counts to sample 
concentration. This is where a very small change in concentration of unlabelled 
ligand produces a large change in amount of label bound to the antibody, and 
where a straight line can be drawn through the points of the standard curve. An 
example of a typical standard curve is shown in figure 2.5. 
2.2.2 Separation methods 
There are two main methods used for the separation of the free unbound label 
from the antibody-ligand complex at the end of the radioimmunoassay. 
The first, used more often in protein assays, is the double antibody method. This 
involves using a second antibody - raised in a different species than the primary 
antibody - against gamma globulins from the species used to raise the primary 
antibody. The second antibody is added to the antibody / unlabelled ligand / 
label mixture after a period of equilibration, and incubated for at least 16 hours. 
The second antibody will bind to the antibody-ligand complex and precipitate out 
of solution, thus halting the dynamic interaction. The precipitate can then be 
compacted by centrifugation, followed by aspiration of the supernatant. The 
amount of bound label in the precipitate is inversely proportional to the amount of 
unlabelled ligand in the sample. 
The second separation method involves the use of activated charcoal, and is 
most often used in steroid assays. Activated charcoal essentially has an 
increased surface area due to the presence of micropores «1 nm) and 
mesopores (1 to 25 nm), therefore small molecules will be adsorbed onto the 
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Figure 2.5 
An example of a typical standard curve obtained in a radioimmunoassay. 
The concentration of the required protein / hormone in the 'unknown' 
sample can be extrapolated from its % Maximum Binding, along the 
straight region of the curve, which lies approximately between 80% and 
20% of Maximum Binding. 
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charcoal. The unlabelled ligand will thus be adsorbed by the activated charcoal, 
and this complex will be precipitated out by centrifugation. The antibody (with 
bound labelled or unlabelled hormone) remains in the supernatant, which is 
decanted directly into beta vials and retained for counting. Albumin or dextran is 
used to fill the mesopores, to prevent adsorption of the bound antibody-ligand 
complex into these larger sites. The timing of the reaction and temperature of the 
assay tubes must be kept constant to avoid excessive variation between assays. 
In a large assay, NSB and MB tubes are also included in each batch of samples 
within the assay, to allow adjustment for batch to batch variation. 
2.2.3 Counting 
Scintillation counters are used to measure radioactivity. In the case of gamma 
radiation (generally used for protein RIAs), gamma rays are emitted from the 
sample and have a high penetrating power; they can therefore travel through the 
plastic assay tube, and strike a thallium coated sodium iodide crystal, which 
emits a flash of light. This light is detected by surrounding photomultipliers, and 
converted into an electrical pulse. The amplitude of this pulse is proportional to 
the intensity of the scintillant and therefore to the energy of the radiation which 
produced it. In steroid radioimmunoassays, beta radiation is more often used. 
This is particulate, and is not highly penetrative, so cannot pass through the 
plastic of the tube. In this case, photons of light are generated within the vial, by 
a liquid scintillant which is activated by the radiation. These photons pass 
through the vials, such that they can be detected by photomultipliers. This 
method reduces the efficiency of the measurement due to the presence of 
impurities - such as proteins or coloured chemicals - in the sample, an effect 
known as quenching. 
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2.3 PROTEIN RADIOIMMUNOASSA YS 
2.3.1 Protein assay buffer (PAB) 
280 ml 0.5 M Na2HP04 and 40 ml 0.5 M NaH2P04 was mixed together to form 0.5 
M NaP04 (pH 7.5), this was added to 2 litres of distilled water. To this solution, 35 
g NaCI, 11.7 g EDTA (not the disodium salt), and 4 g NaN3 was added, and the 
solution was stirred vigorously for 30 minutes. 20 g egg albumin was dissolved 
in 600 ml distilled water. This was added to the mixture, together with a further 1 
litre of distilled water. The solution was stirred for another 2 hours, and the pH of 
the mixture was adjusted to pH 7.05 by adding 5 M NaOH slowly, whilst taking 
continuous readings. The buffer was stirred for a further 1.5 hours and the pH 
was checked once more. The buffer was filtered, and stored at 4°C. 
2.3.2 Purification of label 
The proteins used in these assays (vitellogenin (VTG), follicle stimulating 
hormone (FSH), and luteinising hormone (LH)) were labelled with 1251. Over time, 
the iodine will detach itself from the protein, and this free radioactivity must be 
removed prior to the addition of the labelled protein to the assay, to increase 
sensitivity. A PD10 column, containing Sephadex G25 (Pharmacia), was used to 
achieve this. An appropriate amount of label was purified each time. The label 
was eluted with PA8, whereby 2 radioactive peaks were obtained; the first peak 
was the required labelled ligand, the second was free iodine, as depicted in 
figure 2.6. The labelled ligand could then be diluted as required. 
2.3.3 The vitellogenin radioimmunoassay 
2.3.3.1 Vitellogenin standard 
Purified rainbow trout vitellogenin was obtained from plasma by gel-filtration 
chromatography on a Sepharose 68 column (Pharmacia, Milton Keynes, Bucks, 
UK), prior to ion exchange chromatography on DEAE cellulose (Tyler and 
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Sumpter, 1990). Purified vitellogenin was stored at -20°C in 500 III aliquots of 10 
Ilg/ml. 
2.3.3.2 Vitellogenin antibody 
Antibodies were raised in half lop rabbits injected with purified rainbow trout 
vitellogenin, as described by Sumpter (1985). 
2.3.3.3 Iodination of vitellogenin 
Vitellogenin was labelled with 1251 on tyrosine residues using lodogen (1,3,4,6-
tetrachloro-3a6a-diphenylglycoluril) as an oxidising agent. 5 Ilg rt-VTG (in 20 JlI 
0.1 M sodium phosphate) was added to 10 III 0.5 M sodium phosphate (pH 7.5) 
and 1 mCi Na 1251 on the edge of a 1.5 ml eppendorf vial. The eppendorf vial 
contained 2 Ilg lodogen dried into its base from 20 III of dichloromethane. The 
vial was stood upright to allow the mixture to run to the base, and the reaction 
began. After 10 minutes, the reaction was terminated by the addition of 0.5 ml 
0.1 M sodium phosphate buffer (pH 7.5). This mixture was purified to separate 
free 1251 from labelled vitellogenin using the procedure described above (2.4.2), 
and the labelled vitellogenin was stored at 4°C prior to use. 
2.3.3.4 Routine assay plan 
Duplicate tubes were set up as follows: 
Tubes 1 ,2 Total Counts 
Tubes 3,4 NSB 
Tubes 5,6 MB 
Tubes 7,8 2500 ng/ml VTG standard 
Tubes 9,10 1250 ng/ml 
Tubes 11 ,12 625 ng/ml 
Tubes 13,14 312.5 ng/ml 
Tubes 15,16 156 ng/ml 
Tubes 17,18 78 ng/ml 
Tubes 19,20 39 ng/ml 
Tubes 21,22 19.5 ng/ml 
Tubes 23,24 9.8 ng/ml 
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Tubes 25,26 4.9 ng/ml 
Tubes 27,28 2.4 ng/ml 
Tubes 29,30 Unknown 
Tubes 31,32 Unknown 
... etc 
2.3.3.5 Protocol 
A sensitised 4 day assay was used throughout. The assays were performed as 
follows: 
Day 1 
Plasma samples were diluted in PAB. 50 ~I aliquots of each sample were added 
to reaction tubes (LP2, Luckhams). 1 00 ~I PAB was added to Total Count tubes 
and 50 ~I to MB, NSB, and all but the first pair of standard tubes. Standards were 
serially diluted from the second to the eleventh standard, diluting one entire 
duplicate row before starting the next. 50 ~I of rt-VTG antibody (diluted 1 :100,000 
in 1 :400 NRS) was added to each tube except the Total Counts and the NSB 
tubes. 50 ~I 1 :400 NRS was added to the NSB tubes. Tubes were vortexed, 
centrifuged briefly to ensure the contents were in the base of the tube, and 
incubated at 4 DC overnight. 
Day 2 
Labelled VTG was purified as described above (2.3.2), prior to the addition of 50 
~llabel containing 20,000 to 25,000 cpm/50 ~I to each tube. Tubes were 
vortexed, centrifuged briefly, and incubated overnight at 4DC. 
Day 3 
50 ~I of second antibody (diluted 1 :50 in PAB only) was added to each tube. 
Tubes were again vortexed and centrifuged briefly, and incubated at 4DC for at 
least 16 hou rs. 
Day 4 
Assay tubes were centrifuged at 4DC for 45 minutes at 3000g. The supernatant 
was aspirated and discarded from all tubes except the total count tubes. Pellets 
can be easily disturbed, so care was taken over this procedure, and tubes were 
kept at 4 DC between centrifuging and aspirating if necessary. Each tube 
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(containing antibody-bound labelled or unlabelled VTG) was counted on a 
gamma counter for 2 minutes. The detection limit of this sensitised RIA was 11.2 
ng/ml (n=9). 
2.3.4 The FSH radioimmunoassay 
The FSH radioimmunoassay was run on exactly the same principles as the VTG 
assay, but substituted FSH standard, FSH label, and FSH antibody for the 
corresponding VTG components, as outlined below. 
2.3.4.1 FSH standard 
FSH was purified from rainbow trout pituitary glands according to the method 
described by Swanson et al (1991). 
2.3.4.2 FSH antibody 
FSH antibody was raised in rabbits against FSHB-subunit isolated from coho 
salmon (see Prat et ai, 1996, for details) 
2.3.4.3 Iodination of FSH 
Intact FSH was labelled with 1251 using the method described above for 
iodination of VTG (2.4.3.3). A stock solution of 5 f.!g FSH in 10 f.!1 0.05 M NaP04 
(pH 7.5) was used for the reaction. 
2.3.4.4 Routine assay plan 
The set up of the FSH assay was the same as that for the VTG assay (see 
2.4.3.4), except that the standard curve of 11 standards ranged between 100 and 
0.1 ng/ml, and therefore the "unknown" tubes started from tube number 29. 
2.3.4.5 Protocol 
The assay protocol also followed that used for the VTG assay (2.4.3.5), although 
the activity of the FSH label added to each tube was approximately 3000 cpm. 
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The assays described in this thesis were undertaken using a standard - and a 
label made with this standard - which had been freshly purified from rainbow 
trout (Santos et ai, in prep.); the original assays described in Prat et al (1996) 
used GTH preparations from coho salmon, Oncorhynchus kisutch, a species 
which is closely related to rainbow trout. The resulting assay was slightly more 
sensitive than that described by Prat et ai, and had a detection limit of 1 ng/ml. 
The specificity of this assay was adequate, but the FSH assay is not as specific 
as the LH assay, and there was a <10% cross-reaction with homologous 
hormones (LH, free GTHu, free FSHB; Santos et ai, in prep). 
2.3.5 The LH radioimmunoassay 
The LH radioimmunoassay was also performed using the same procedure as the 
VTG assay, except substituting LH standard, LH antibody, and LH label for the 
respective VTG components, as described below. 
2.3.5.1 LH standard 
LH purified from coho salmon was used in these assays, as supplied by Dr. 
Penny Swanson (Swanson et ai, 1991). 
2.3.5.2 LH antibody 
Antibodies against the B-subunit of LH were raised in rabbits as described by 
Prat et al (1996). 
2.3.5.3 Iodination of LH 
Iodination of purified LH was performed using the lodogen method as described 
above (2.4.3.3), using a stock of 2 Jlg LH contained in 10 JlI 0.05 M NaP04 (pH 
7.5). 
2.3.5.4 Routine assay plan 
LH standard was diluted over 10 steps from 10 ng/ml to 0.02 ng/ml for the 
standard curve. "Unknown" samples therefore started from tube 27 of the assay. 
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Otherwise, the assay plan was the same as described for the VTG 
radioimmunoassay. 
2.3.5.5 Protocol 
The assay protocol also followed that used for the VTG assay (2.4.3.5), although 
the activity of the LH label added to each tube was approximately 5000 cpm. This 
assay was both sensitive and highly specific, with a detection limit of 0.26 ng/ml, 
and a cross-reactivity (with FSH) of <0.001 % (Prat et ai, 1996). 
2.4 STEROID RADIOIMMUNOASSA YS 
The general principal of a steroid RIA has been described in section 2.2. 
2.4.1 Steroid assay buffer (SAB) 
Buffer was prepared by making 1 litre of 0.05 M phosphate buffered saline (PBS; 
Oxoid). 1 g of gelatine (Type A: from porcine skin; Sigma) was added to the 
solution. The mixture was heated on a stirring block until the gelatine had 
dissolved. The solution was allowed to cool prior to the addition of 1 g sodium 
azide. 
2.4.2 Routine assay plan 
Owing to the importance of timing at the separation (using activated charcoal) 
stage, the addition of charcoal must take place quickly to minimise variability 
between the first and last tubes; therefore, assays were split into batches, each 
containing approximately 40 tubes (20 samples). E2 standards were serially 
diluted from 5 ng/ml to 0.0025 ng/ml, giving 12 dilutions in total, and testosterone 
standards were diluted from 10 ng/ml to 0.01 ng/ml (11 dilutions). After every 40 
tubes, a new "batch" would start, with fresh NSB and MB tubes also. An example 
of an E2 assay plan would therefore be as follows. 
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Tubes 1 ,2 Total Cou nts 
Tubes 3,4 NSB 
Tubes 5,6 MB 
Tubes 7,8 5 ng/m I E2 standard 
Tubes 9,10 2.5 ng/ml 
Tubes 11 ,12 1.25 ng/ml 
Tubes 13,14 0.625 ng/ml 
Tubes 15,16 0.313 ng/ml 
Tubes 17,18 0.156 ng/ml 
Tubes 19,20 0.078 ng/ml 
Tubes 21,22 0.039 ng/ml 
Tubes 23,24 0.02 ng/ml 
Tubes 25,26 0.01 ng/ml 
Tubes 27,28 0.005 ng/ml 
Tubes 29,30 0.0025 ng/ml 
Tubes 31,32 Unknown 1 
Tubes 33,34 Unknown 2 
Tubes 35,36 Unknown 3 
Tubes 37,38 Unknown 4 
Tubes 39,40 Unknown 5 
Tubes 41,42 NSB 
Tubes 42,43 MB 
Tubes 44,45 Unknown 6 
Tubes 46,47 Unknown 7 
... etc 
2.4.3 Assay protocol 
Plasma samples were extracted with ethyl acetate prior to assay. This separates 
the steroids from their sex steroid binding proteins. An appropriate volume of 
plasma was transferred to a polypropylene tube, followed by 1 ml ethyl acetate. 
The volume of plasma used here was normally 200 J.l1, but dilution rates varied 
according to the expected plasma E2 or testosterone concentration of the fish at 
the relevant stage of the reproductive cycle; in addition, a greater volume of 
plasma was required from the fish exposed to 100 J.lg 4-NP/L (see chapter 4) due 
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to the suppressed steroid titres. The tube was capped, shaken, and stored at 
-20°C. 
Day 1 
The samples (plasma plus ethyl acetate) were spun at 2500g for 2 minutes to 
separate the ethyl acetate (top layer) from the plasma (lower layer). The ethyl 
acetate, containing the extracted steroid hormone, was decanted into another 
tube. The ethyl acetate was then removed using a Gyrovap, and the steroid 
remaining was redissolved in 100 JlI SAB. 200 JlI SAB was added to the total 
counts and NSB tubes; 100 JlI was added to each standard tube except the first 
pair. Standard was serially diluted from the second to the last standard, for an 
entire row, before serially diluting a duplicate row of standards. 
100 JlI of labelled (tritiated) hormone (approximately 9000 disintegrations per 
minute (dpm) for E2; approximately 6000 dpm for testosterone) was added to 
each tube. 100 JlI of antibody (diluted 1 :200,000 for E2, 1 :50,000 for 
testosterone) was added to all tubes except the total counts and NSB tubes. 
Tubes were vortexed and centrifuged briefly to ensure the contents were in the 
base. 
Day 2 
As mentioned previously (2.2.2), activated charcoal was used to separate the 
bound complex from the unbound label. Dextran-coated charcoal was prepared 
(0.5% activated charcoal; 0.05% dextran in SA B) 15 minutes prior to use. 
500 JlI SAB was added to the total count tubes. 500 JlI activated charcoal mixture 
was added to each of the remaining tubes (one batch at a time), the tubes were 
vortexed and incubated on ice for 10 minutes prior to centrifuging at 2500g for 15 
minutes, at 4°C. The supernatant (containing the bound fraction) was removed 
and transferred to scintillation vials to which 4 ml scintillation fluid (Liquiscint, 
National Diagnostics) was added. The tubes were shaken and counted in a B-
counter for 5-10 minutes. 
Calculations were carried out by hand using the mean dpm for each pair of tubes 
and applying the following equation: ((unknown-NSB) / (MB-NSB)) x 100. The 
standard curve was plotted on log-normal paper, and the unknown values were 
read from this curve. 
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The 17B-estradiol assay was both highly specific and highly sensitive; the 
detection limit was 0.028 ng/ml (n=11); the cross reactivity with other estrogens 
(estrone and estriol) was <0.5%, and with other steroids was <0.005% 
(Carragher, 1988). The testosterone assay was similarly sensitive and specific; 
the detection limit was 0.033 ng/ml (n=3) and the cross-reactivity with other 
steroids ranged from 2.4% (11-ketotestosterone) to <0.01 (various 
progesterones) (Scott et ai, 1984). 
2.5 EXTRACTION AND ANAL YSIS OF WATER SAMPLES 
Water samples from in vivo experiments (in which fish were exposed to 
chemicals) were collected at intervals, extracted, and analysed using both 
analytical chemistry and a bioassay (the recombinant yeast screen). Analytical 
chemistry provided a more accurate determination of actual concentration of test 
chemical in the sample, whereas the yeast screen measured the estrogenicity of 
the water in the dosed tanks compared to that of the control tanks. General 
techniques followed those described by Janbakhsh (1996). 
2.5.1 Collection and storage 
Water samples were collected in solvent-rinsed glass bottles and preserved with 
10 ml of 38% formaldehyde per litre. Samples were stored in the dark at 4°C 
prior to extraction, for a maximum of 1 week. 
2.5.2 Extraction 
Samples were concentrated using solid phase extraction on Sep-Pak cartridges 
which contain a sorbent packing material to which organic matter in the water 
samples partitions. In these experiments, Sep-Pak cartridges containing a 
packing material of 200 mg ethyl bonded silica (C2; JT Bakers, Berkshire, UK) 
were used. These were reported to have a better ability to recover alkylphenols 
from water, compared to those containing the frequently used octadecyl (C18) 
packing material (Janbakhsh, 1996). 
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A simplified diagram of the procedure is shown in figure 2.7. A 12-port Visiprep 
solid phase extraction manifold (Supelco, Dorset, UK) was used to extract 
multiple samples. The cartridges were first primed with 5 ml methanol, followed 
by 5 ml ddH20. The sample was then loaded onto the cartridge and drawn 
through at a rate of approximately 5 ml/min. The cartridge was washed with 3 ml 
ddH20, and dried by drawing air through the cartridges for 30 minutes. The 
samples were then eluted with 5 ml methanol. The methanol was evaporated 
using a stream of oxygen-free nitrogen, and the sample redissolved in an 
appropriate volume of solvent, depending on the concentration of the original 
sample and the detection limit of the assay used in the final analysis. 
2.5.3 Analysis of extracted samples 
Water extracts were analysed for estrogenic activity using the recombinant yeast 
assay (see section 2.1.1) and for accurate determination of chemical 
concentrations using analytical chemistry techniques. 
Water samples collected from the dosing experiment in which rainbow trout were 
exposed to varying doses of 4-NP were analysed by normal-phase HPLC, 
followed by fluorescence detection. The method used is described in Janbakhsh 
(1996). Briefly, the HPLC system Crystal 200 Liquid Chromatograph (ATI 
Cambridge) consisted of quarternary solvent proportioning valves and duel 
piston pump head. The sample injection was carried out by a LC230 auto-
sampler (ATI Cambridge) with a 20 JlI sampling loop. The LC-NH2 normal phase 
analytical column (Supelcosil, 25.0 cm, 4.6 mm, 5 Jlm) was used for separation. 
The determinands were detected by a FL2000 Spectra-System Fluorescence 
detector, at excitation and emission wave-lengths of 230 nm and 302 nm, 
respectively. The data were integrated and recorded by a Unicam 4815 
computing integrator (ATI Cambridge). 
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chemical present in water samples prior to analysis by HPLC or bioassay. 
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CHAPTER 3 
AN ASSESSMENT OF THE ENDOCRINE 
DISRUPTING POTENTIAL OF 
PHTHALATE ESTERS 
Data from this chapter have been published in: 
Harris CA, Henttu P, Parker MG, Sumpter JP (1997) The estrogenic activity of 
phthalate esters in vitro. Environ. Health Perspect. 105: 802-811 
Harries JE, Runnalls T, Hill E, Harris CA, Maddix S, Sumpter JP, Tyler CR 
(2000) Development of a reproductive performance test for endocrine disrupting chemicals 
using pair-breeding fathead minnows (Pimephales promelas). Environ. Sci. Technol. 34: 
3003-3011 
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3.1 INTRODUCTION 
3.1.1 The abundance of phthalates in the modern 
environment 
Phthalate esters are among the most widely used industrial chemicals in 
existence. They are used principally as plasticisers, to impart flexibility, 
workability, and durability to polymers, but they can also be found in products 
such as paints, adhesives, inks and cosmetics. Millions of tonnes of phthalates 
are produced world-wide every year, with hundreds of thousands of tonnes being 
used in Europe alone (see table 3.1). The significance of phthalate consumption 
lies in the fact that their applications are widespread and extremely diverse. This, 
together with the fact that their very nature determines that they are fluid within 
the materials to which they are added, and thus can leach from these media, 
leads to the ubiquitous presence of phthalates in environmental samples. On the 
other hand, phthalates are far more reactive than many other industrial organic 
contaminants with low solubilities, and therefore degrade more easily in the 
environment; thus although the input is constant, the final concentration may be 
lower than initially expected. Consequently, major questions that arise are "what 
do they degrade to?", and "are the intermediate degradation products harmful in 
themselves?" 
Mass Consumed 
Name Abbr. Molecular Solubility log Kow * in Europe 
Weight (mg/L) * (tonnes/annum) 
Di(2-ethylhexyl) phthalate DEHP 390.56 0.003 7.5 400-500,000 
Diisononyl phthalate DINP 425 <0.001 >8.0 100-200,000 
Diisodecyl phthalate DIDP 447 <0.001 >8.0 100-200,000 
Butyl benzyl phthalate SSP 312.39 2.7 4.59 20-50,000 
Dibutyl phthalate DSP 278.35 11.2 4.45 20-40,000 
Diisobutyl phthalate DISP 278.35 20.0 4.11 20-40,000 
Table 3.1 
Details of the high volume use phthalates (>20,000 tonnes/annum in Europe). 
An asterisk indicates that the data were taken from Staples et al (1997). 
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The basic structure of a phthalate ester comprises an aromatic ring with 2 
aliphatic side chains. There are more than 60 different phthalates in use. 
Generally, however, only a small number are used in large quantities in Europe; 
these are listed in table 3.1, and their structures are shown in figure 3.1. As a 
class, the popularity of phthalates as plasticisers is owed to their inertness, 
fluidity, and high solubility in the polymer (Giam et ai, 1984). Also significant are 
their low water solubilities, and low volatilities, which help prevent loss from the 
polymer and thus ensure the continued flexibility of the plastic. The lengths of the 
side chains determine the properties of each individual phthalate, and therefore 
its end use. 
Di-2-ethylhexyl phthalate (DEHP) is by far the most widely employed phthalate, 
and hence much of the research into the behaviour and toxicity of this class of 
chemicals has focused on DEHP and its metabolites. The major end use of 
DEHP is as a plasticiser in polyvinyl chloride (PVC), in which it can frequently be 
found forming up to 40% of the end product. Applications of this type of PVC 
include such human contact materials as childrens' toys and blood bags. Other 
phthalates used in large volumes that will also feature prominently in this chapter 
include butylbenzyl phthalate (SSP), which is primarily used to make vinyl floor 
tiles, but has alternative applications, for example in car upholstery and 
adhesives, and dibutyl phthalate (DSP), used primarily as a plasticiser, but which 
also has a wide variety of non-plasticiser applications, such as an ingredient in 
paints, inks, glue, nail polish, hair spray, and insect repellents (Lyons, 1995). 
Diisononyl phthalate (DINP) is also currently under investigation, not only 
because it is a high volume use phthalate, but also because a number of recent 
studies have discovered significant concentrations (constituting up to 50% of the 
product) in childrens' toys, many of which are designed specifically for sucking by 
young children; for example, teethers (Stringer et ai, 1997; Rastogi, 1998). Since 
very young children are known to be at a very sensitive stage of development, it 
is important to know that they are safe from any chemicals to which they may be 
exposed, be it in low doses chronically, or in a high acute dose. There are 
currently many calls from consumer groups to ban the use of phthalates in toys, 
and several retailers already have a voluntary commitment to removing such 
products from their shelves. Hence, the use pattern of phthalates as discussed 
here may well alter in the near future. 
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3.1.1.1 Fate of phthalates in the aquatic environment 
Phthalates can enter the aquatic environment via a number of pathways. These 
include in industrial waste direct from processing plants, in leachate from 
disposal of end products, in domestic and industrial sewage effluents, and in 
waste from vehicle washing. 
It is generally accepted that biodegradation of phthalates in water is relatively fast 
(the half life obtained from shaking flask studies being reported as a matter of 
days, as opposed to months or years for some chemicals (Sugatt et ai, 1984)), 
and therefore measured concentrations of the parent compounds are, on the 
whole, in the range of the low 1l9/L to undetectable. However, this does not rule 
out accumulation of phthalates in the often anaerobic sediments of aquatic 
environments, which may lead to exposure of sediment dwelling or feeding 
organisms. Indeed, the log Kow values (see table 3.1 for some examples) 
calculated for phthalates (ranging from 7.5 for the longer chain DEHP, to 4.45 for 
DBP, and 1.61 for the short chain dimethyl phthalate (DMP) (Staples et ai, 1997) 
suggests that phthalates, particularly those with longer side chains, may have a 
tendency to bind to particulate matter, which will settle out to form sediment. This 
is supported by the data of Long et al (1998), who detected concentrations of 
DEHP in water around the low 1l9/L mark, with the highest measurement being 
21 1l9/L, whereas in the same rivers, concentrations of up to 115 mg/kg were 
measured in suspended sediment samples, with a general trend of higher 
concentrations of phthalates in suspended sediments than in bed sediments 
being observed. The concentration of DEHP in the sediments of all but two 
samples was in the low mg/kg to the 1 D's of mg/kg range, therefore being at least 
3 orders of magnitude higher than the concentration measured in the 
corresponding water samples. 
Sewage effluent samples have also been found to be contaminated with 
phthalate residues. Concentrations of DEHP up to 245 1l9/L were found in 
Scottish effluents (Pirie et ai, 1996). In that particular study, DEHP was detected 
in 59% of samples taken. Other phthalates, such as DEP, DBP, DIBP, and BBP, 
were also detected, but at reduced frequency and far lower concentrations. 
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3.1.1.2 Fate of phthalates in the terrestrial environment 
Phthalates have also been reported in samples taken from various compartments 
of the terrestrial environment, including the atmosphere, sludges, soils, landfill 
sites, and plants. 
One route of entry of phthalates into soil systems is via the application of sewage 
sludge to soil. Large volumes of sludge are disposed of to agricultural land, 
providing beneficial soil fertilising and conditioning properties. Another potential 
route of entry is via fallout from the atmosphere, as discussed by Thuren and 
Larsson (1990). They reported mean air concentrations of DEHP and DBP in the 
low ng/m3 range, similar to those detected by Giam et al (1980) in the 
atmosphere of the Gulf of Mexico. The latter study found DEHP and DBP to be 
associated with both the particulate and the vapour phase in the air. 
A summary of the properties of individual phthalates controlling their fate in the 
environment (such as solubility, log Kow, and vapour pressure) can be found in 
Staples et al (1997); solubilties and log Kow values of the high-volume use 
phthalates can be seen in table 3.1. 
3.1.1.3 Degradation of phthalates in the environment 
Despite the constant input and widespread distribution of phthalates into 
environmental systems, the rapid degradation of these chemicals is of paramount 
importance in preventing, in most instances, their accumulation. As a rule, 
biodegradation pathways are dominant in surface waters, soils, and sediments, 
whereas photodegradation prevails in the atmospheric compartment (Staples et 
ai, 1997). 
The degradation rates of phthalates are dependent on their molecular weight; 
those with longer alkyl side-chains tend to have longer half-lives in a given 
environment. This phenomenon was observed by Shelton et al (1984), who 
found DnOP and DEHP to remain intact in anaerobic digester sludge, whereas 
the lower molecular weight DMP, DEP, and DBP were completely mineralised, 
as was BBP, albeit at a slightly reduced rate. A similar picture was reported by 
Ejlertsson et al (1996, 1997), who found that more soluble phthalates were 
degraded in anaerobic conditions, whilst less soluble esters were not. In aerobic 
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environments, e.g. activated sludge systems (O'Grady et ai, 1985), or the 
modified Sturm test (Scholz et ai, 1997), the higher molecular weight phthalates 
can also be transformed, albeit at a slower rate than those with shorter alkyl side-
chains. 
It can be concluded that there is a general trend for decreasing biodegradability 
of phthalates corresponding to increasing molecular weight. Hence, DEHP, the 
most prolific phthalate in use today, is also one of the most persistent in the 
environment (Rogers, 1996). 
3.1.1.4 Exposure of humans to phthalates 
The majority of studies discussing exposure of humans to phthalates involve oral 
exposure, for instance through ingestion of food, or the chewing of toys by small 
children. Other potential routes may include skin contact, for example from 
constantly handling plastic articles, contact with PVC clothing or vinyl childrens' 
pants, and cosmetics; or inhalation, for example as a result of sitting in a car 
where phthalates are volatilising from upholstery into the atmosphere of the car 
interior. However, due to the difficulties associated with quantifying such 
exposure, there are no actual data on the degree of exposure via these latter two 
pathways; therefore, whilst they must be borne in mind, the attention here will 
focus upon oral exposure of humans to phthalates. It must also be considered 
that any exposure estimates are just that, estimates, and too much weight should 
not be placed on such subjective analyses. 
DINP and DEHP can in many cases make up 10 to 40% by weight of PVC toys, 
including teethers which are intended to be put into the mouths of small children 
(Stringer et ai, 1997; Rastogi, 1998). These studies established concentrations 
of phthalates in the toys, but not their leaching potential. This latter question has 
been addressed by Steiner et al (1998) and Vinklesoe et al (1997); the former 
found DEHP leaching from PVC child articles into a saliva simulant, and the latter 
reported the leaching of a range of phthalates from PVC teethers. These data 
demonstrate a real possibility of exposure of young children to phthalates from 
PVC toys. 
Exposure of humans to phthalates via food is also a potential risk, as is 
evidenced by the number of studies which have analysed phthalates in food 
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packaging materials (MAFF, 1995; van Lierop, 1997; Nerin et ai, 1998), the 
migration of phthalates from such packaging (Harrison, 1998), and the 
subsequent concentrations of various phthalates in food products (MAFF, 1996a; 
MAFF, 1996b; MAFF, 1998; Sharman et ai, 1994; Petersen, 1991; Page and 
Lacroix, 1995). It should be made clear, however, that some researchers 
consider increased phthalate concentrations to arise not only from packing 
materials, but also from general environmental contamination during, for 
example, the processing of the food products (MAFF, 1996a; Sharman et ai, 
1994). Young children are at a particularly sensitive stage of development, and 
surveys have been carried out to assess the extent of phthalate contamination in 
infant formulae. An initial survey found total phthalate concentrations of 1.2 to 
10.2 mg/kg (MAFF, 1996b), but a follow-up survey has reported reassuringly 
lower concentrations in similar samples, of <0.1 to 0.6 mg/kg (MAFF, 1998), 
thereby lowering the overall exposure of infants fed on these diets to within set 
safety limits. 
The exposure of humans to phthalates is unquantifiable, owing to the ubiquity of 
these chemicals and the considerable number of potential pathways of exposure, 
many of which scientists have not even attempted to assess. Therefore, it is not 
possible to state that the apparently low levels of exposure from food products, 
however encouraging they are, indicate an intake which is safe overall. 
3.1.1.5 Exposure of aquatic organisms to phthalates 
There is a distinct lack of research specifically devoted to exposure of aquatic 
organisms to phthalates. Briefly, however, pathways may include: intake via the 
gills of fish, uptake through food sources (which may themselves have absorbed 
phthalates from the water, or ingested food which had done so), intake of 
suspended sediments, and uptake due to living or feeding in the sediments of the 
water body floor. Uptake via the gills of fish is potentially an especially direct 
source of contaminant to the bloodstream, because the blood reaches many 
organs before passing through the liver, where most metabolism will occur, and 
thus this route of exposure should be researched more fully. 
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3.1.1.6 Metabolism and bioaccumulation 
Metabolism of environmental contaminants can have major implications when 
considering their mechanisms of toxicology. In vitro assays seldom, possibly 
never, display the same metabolic pathways as whole organisms, and hence, if 
any effects of toxicants (such as phthalates) are due to metabOlites, rather than 
the parent compounds, then only in vivo studies can provide the necessary 
information; results of in vitro assays, by themselves, may be misleading. 
The primary metabolites of phthalates are their monoesters. The first step in 
phthalate degradation is hydrolysis, whereby one of the side chains is cleaved, 
leaving the monoester plus an alcohol group. Examples are shown in figure 3.2. 
3.1.1.7 Metabolism and bioaccumulation of phthalates in aquatic 
organisms 
Stalling et al (1973) exposed channel catfish to DEHP and found MEHP to be the 
major metabolite, with 66% of DEHP converted to MEHP after a 24 hour 
exposure to 1 J.lg DEHP/L. They also exposed fathead minnows to DEHP, and 
found that the ratio of MEHP:DEHP was lower compared to that observed in the 
channel catfish. However, the concentrations of DEHP and exposure periods 
were different, so the experiments are not comparable (Stalling et ai, 1973). In 
the same study, the authors used hepatic microsomes to examine metabolism of 
DBP and DEHP. Degradation of DBP reached 97% after 2 hours, whereas only 
6% of DEHP was metabolised in the same length of time. 
In the Bluegill Sunfish, metabolism of BBP was studied (Carr et ai, 1997). The 
bioconcentration factor (BCF) for intact BBP was found to be 9.4 (for the whole 
fish). This was compared to estimated BCF values calculated by 4 different 
groups of scientists, using physical properties such as Kow and solubility, of 
3174, 2528, 705, and 304 (cited by Carr et ai, 1997), which appear to be vast 
overestimates. The degradation products of BBP were not characterised by Carr 
et al (1997). Algae (e.g. Chlorella pyrenoidosa) have perhaps higher potential 
for accumulation of phthalates, but despite their BCFs reaching maxima of 162 
(after 24 hours), 205 (after 12 hours), and 4077 (after 12 hours) for DMP, DEP 
and DBP, respectively (Van et ai, 1995), they were also found capable of 
metabolising these chemicals to a certain extent. 
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Despite these studies, our knowledge of metabolism of phthalates in aquatic 
organisms is relatively poor. It is dangerous to generalise from the limited, and 
fragmented, information available to all aquatic organisms, both plants and 
animals, the latter ranging from invertebrates to higher vertebrates, which inhabit 
the variable aquatic environment. 
3.1.2 The reported endocrine activity of phthalates 
Certain phthalates have been recognised for many years as reproductive 
toxicants (a summary of the testicular toxicity of phthalates can be found in 
Gangolli, 1982). Essentially, the studies report decreased testicular weight, and 
seminiferous tubular atrophy, induced by DEHP, DBP, di-n-propyl phthalate 
(DnPP), and di-n-hexyl phthalate (DnHP), as well as by their respective 
monoesters. With respect to DEHP in particular, further studies by Gray and 
Gangolli (1986) led them to conclude that MEHP is, in fact, the active testicular 
toxin produced as a result of metabolism of DEHP in vivo. Ema and colleagues 
have also undertaken numerous studies in an effort to elucidate the reproductive 
and developmental toxicity of phthalates to rats exposed in utero. These studies 
have revealed that BBP and DBP can induce decreased uterine and ovarian 
weights, and increase postimplantation embryonic loss (Ema et ai, 1994, 1997). 
More recently, the same scientists have found that DBP, administered to rats 
during the latter half of pregnancy, had an overall adverse effect on the 
reproductive development of male fetuses (Ema et ai, 1998); these data are 
supported by those of Imajima et al (1997), who demonstrated that rats exposed 
in utero to MBP (the major metabolite of DBP) exhibited increased incidences of 
cryptorchidism. Furthermore, a multigenerational study by Wine at al (1997) 
highlighted effects of DBP on the reproductive development of F1 generation rats, 
whereas fewer adverse effects had been seen in the Fo generation. This latter 
study was originally published as in internal report for the National Toxicology 
Program in the US (Gulati et ai, 1991). However, following the recent research 
on the endocrine activities of phthalates, a reassessment of such work has been 
undertaken, as a possible explanation for the reproductive toxicity of the 
phthalates has been provided (see below). 
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3.1.2.1 Estrogenic activity in vitro 
The first report of estrogenic activity of phthalates was published as recently as 
1995. Jobling et al (1995) assayed a number of xenobiotics in several in vitro 
assays, and found BBP, DBP, and DEHP competed with E2 for binding to the 
rainbow trout ER, albeit weakly so. That is, very high concentrations were 
required, and even at the highest concentration tested, the response was far less 
than the maximal response elicited by E2 itself. The same scientists investigated 
these phthalates for their ability to induce proliferation of ZR-75 breast cancer 
cells - a response specifically stimulated by estrogens. In that assay, only BSP 
and DBP were found to be estrogenically active, and again, their responses were 
less than maximal. The third assay performed by Jobling et al (1995) assessed 
the abilities of the chemicals to stimulate transcriptional activity of the human 
estrogen receptor. In this assay, as in the former two, BBP was found to be the 
more potently estrogenic phthalate, DBP was also active, as was DEHP (albeit 
only at concentrations exceeding 1 x1 0-4 M). This pattern of estrogenic activity of 
these phthalates has been repeated in the majority of studies reporting the 
results of in vitro assays published since the paper of Jobling et al (1995). There 
are some exceptions, such as data from Soto et al (1995), who concluded that of 
all the phthalates tested in the "E-Screen" (monitoring the proliferation of MCF-7 
breast cancer cells), only BBP was estrogenic. These authors concluded that the 
alkyl phthalates were not estrogenic, although it was not clear at what 
concentrations they had been tested, and therefore it may be that the 
concentrations of alkyl phthalates used were simply not high enough to stimulate 
a response. Another example of data contrasting with those reported by Jobling 
et al (1995) was published by Gaido et al (1997), who found BBP, at 
concentrations up to 1 x1 0-4 M, to be inactive in a yeast-based estrogen assay. 
Petit et al (1997) used a novel in vitro yeast-based assay, in which the yeast had 
been transformed with a gene coding for the rainbow trout estrogen receptor. 
DEHP was not estrogenic in this assay, but DBP was weakly active. Both of 
these phthalates were inactive in a competitive binding assay based on the 
rainbow trout estrogen receptor, and DBP was found not to induce vitellogenin 
mRNA production (an estrogen-specific response) in hepatocyte cell cultures 
(Petit et ai, 1997). Another recombinant yeast-based assay, this time with the 
yeast transformed with a gene for the human ER, found BBP to be estrogenically 
active, but DBP and DEHP were inactive (Coldham et ai, 1997). In this study, 
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SSP was also tested in an in vivo assay, namely the mouse uterotrophic assay 
(in which the endpoint is relative uterine weight, an increase in uterus weight 
indicating an estrogenic stimulus) and found to be inactive. 
Zacharewski et al (1998) recently reported the results of testing 8 phthalates 
(DEHP, DSP, SSP, DHP, DIHP, DnOP, DINP, and DIDP) in a battery of in vitro 
and in vivo assays, and found DSP, SSP, and DHP to be weakly estrogenic in 
both an ER competitive binding assay and in a gene expression assay 
employing transfected MCF-7 cells. The in vivo assays undertaken in that study 
included a uterine wet weight assay, and a vaginal cell cornification assay, the 
endpoints of which are controlled by estrogenic stimuli. Rats were dosed orally 
with high concentrations of phthalate (20, 200, and 2000 mg/kg). Despite SSP, 
DSP, and DHP displaying definitive interaction with the estrogen receptor in vitro, 
none of the phthalates tested were able to induce estrogenic responses in these 
in vivo experiments (Zacharewski et ai, 1998). 
Knudsen and Pottinger (1999) tested DEP, DAP, DSP, SSP, and DEHP in a 
rainbow trout estrogen receptor binding assay. All were active, although the 
responses were less than 30% of the maximum, and the response curves were 
not parallel to that produced by the positive control, E2. The same chemicals 
were tested for affinity for the rainbow trout testosterone and cortisol receptors, 
but none were found to interact with either of these receptors. 
3.1.2.2 Estrogenic activity of phthalates in vivo 
The relatively recent realisation that some phthalates are weakly estrogenic in 
vitro has obviously raised concerns that they may also be estrogenic in vivo. 
Data discussing the in vivo estrogenicity (or lack of it) of phthalates are scarce, 
but have recently begun to emerge. The reason for the slow appearance of such 
data is the length of time required to undertake sound in vivo studies, together 
with their expense, and the lag time prior to such data reaching the public 
domain. Therefore, from the first reported incidence of estrogenicity (in vitro) in 
1995 (Jobling et ai, 1995), to date only a few articles have been published where 
the aim of the study was to assess estrogenic effects of phthalates in vivo. The 
following discussion includes some reports of effects which may not have been 
specifically estrogenically stimulated; however, the papers were written with 
endocrine disruption in mind. 
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The first documented evidence of apparent estrogenicity of a phthalate in vivo 
was published by Sharpe et al (1995). Adult female Wistar rats were dosed with 
SSP via drinking water, from 2 weeks prior to mating, through gestation, and until 
day 22 after giving birth. Subsequently, the offspring were maintained under 
normal conditions until the experiment was terminated at postnatal day (pnd) 90-
95. These authors observed (in the male offspring) a decrease in testis weight, 
along with a decrease in relative testis weight and testis/kidney weight ratio, and 
also a decrease in daily sperm production, which was proportional to the drop in 
testis weight (Sharpe et ai, 1995). It was clearly stated by the authors that there 
was no evidence of a specifically estrogenic mechanism, although it is unlikely 
that it was a purely toxic one, since body weight and kidney weight of the 
exposed animals were normal. Since the publication of these data, attempts 
have been made to repeat the experiments (Ashby et ai, 1997a). However, there 
were no adverse developmental effects observed in these later studies. The 
reason for the different results obtained from the two studies is unclear, and 
hence Ashby et al (1997a) were hesitant to refute Sharpe's study, and instead 
described their data as "failing to confirm" that reported by Sharpe et al (1995). 
There are some reports of phthalates having been tested in mammals in vivo 
where the endpoint was specifically dependent upon an estrogenic stimulus. 
Examples of such endpoints include an increase in relative uterine weight, 
vaginal cell cornification, and increased uterine vascular permeability. SSP was 
found to be inactive in the uterotrophic assay (Cold ham et ai, 1997). None of the 
phthalates tested by Milligan et al (1998) - namely DOP, DSP, SSP - stimulated 
an increase in uterine vascular permeability in ovariectimised mice. Zacharewski 
et al (1998) tested eight different phthalates (see above) in the uterine wet weight 
and the vaginal cell cornification assays, and found that all were inactive as 
estrogens. Thus, there is a consensus of opinion presently that the phthalates 
tested to date do not demonstrate estrogeniC activity, even when administered 
(orally) at high doses, in short-term rodent bioassays. 
3.1.4.3 Anti-androgenic activity of phthalates 
The most recent hypothesiS on the mechanisms behind the reproductive toxicity 
of phthalates is that, rather than behaving as estrogen mimics, they may in fact be 
having an inhibitory effect on androgen activity; that is, that they are 'anti-
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androgens'. The first documented evidence for this idea was published in 1998, 
when Sohoni and Sumpter (1998) reported BBP to have antagonistic activity in a 
recombinant yeast-based androgen screen. This behaviour of phthalates will be 
discussed further in the following sections of this chapter. 
3.2 METHODS 
3.2.1 Recombinant yeast assays 
The majority of phthalates used in these experiments were purchased from 
Greyhound Chemservice (Merseyside, UK). These were of approximately 97 -
99% purity. A total of 35 phthalate esters were assessed for estrogenic activity. 
Those which are used in large amounts in Europe have been discussed already, 
and are listed in table 3.1. However, the majority of the phthalates assayed do 
not have any appreciable usage in Europe, and these are listed in table 3.2. 
Commercial phthalate samples were also assessed for estrogenic activity in the 
recombinant yeast assays. These were obtained from: BP Chemicals Ltd., Hull, 
UK (DBP, 99.7%; DIBP, 99.6%; DEP, >99.7%; DOP, 99.9%); EXXON Chemical 
Ltd., Fareham, UK (DIDP, 99.9%; DINP, 99.9%); EXXON Chemical Ltd., 
Courbevoie, France (DTDP, purity not specified); and Monsanto Europe S.A., 
Louvain-Ia-Neuve, Belgium (BBP, >98.5%). 
Phthalate metabolites were also donated by Dr. R. Bos, University of Nijmegan 
(MHP, MEHP, MPP, MnOP; and metabolites V, VI, and IX of DEHP - see Dirven et 
ai, 1993); and Monsanto Europe S.A. (MBP and MBzP). 
Other chemicals used in these assays were 17B-estradiol, dihydrotestosterone, 
and flutamide (Sigma, Poole, Dorset). o,p'-Bisphenol A was obtained from DOW 
Europe S.A., Horgen, Switzerland. 
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Mass Consumed 
Name Abbr. in Europe 
(tonnes/annum) 
Ditridecyl phthalate DTDP 3-10,000 
Diethyl phthalate DEP (with DMP) 10-20,000 
Dimethyl phthalate DMP (with DEP) 10-20,000 
Diisohexyl phthalate DIHP <2000 
Diundecyl phthalate DUP <2000 
Butyl decyl phthalate BDcP <1000 
Butyl octyl phthalate BOP <1000 
Dicyclohexyl phthalate DCHP <1000 
Dihexyl phthalate DHP not alone 
Di-n-octyl phthalate DnOP not alone 
Bis(2-n-butoxyethyl) phthalate DBoEP negligible 
Bis[2-(2-ethoxyethoxy)ethyl] phthalate DEoEoEP negligible 
Bis(ethoxyethyl) phthalate DEoEP negligible 
Bis(2-ethylhexyl) hexahydrophthalate DEHhP negligible 
Bis(2-ethylhexyl) isophthalate DEHIP negligible 
Bis(methoxyethyl) phthalate DMEP negligible 
Butyl cyclohexyl phthalate BCHP negligible 
Butyl 2-ethylhexyl phthalate BEHP negligible 
Butyl isodecyl phthalate BiDP negligible 
Diamyl phthalate DPeP negligible 
Dimethyl isophthalate DMIP negligible 
Dioctyl isophthalate DOIP negligible 
Diphenyl phthalate DPhP negligible 
2-Ethylhexyl isodecyl phthalate EHIDP negligible 
Hexyl decyl phthalate HDP negligible 
Hexyl 2-ethylhexyl phthalate HEHP negligible 
Isodecyl tridecyl phthalate IDTDP negligible 
Octyl isodecyl phthalate OiDP negligible 
Isohexylbenzyl phthalate IHBP negligible 
Table 3.2 
Phthalates which were tested in the recombinant yeast estrogen assay, but which 
are not used commercially in high volumes in Europe. 
The method used to assess estrogenic activity of phthalates in the recombinant 
yeast assay has been described in section 2.1.1. Phthalates were serially diluted 
over 12 steps, from 10-3 M, in the assay. E2, DHT, and flutamide were serially 
diluted from 10-8 M, 5x1 0-8 M, and 10-3 M, respectively. 
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The procedure for the anti-androgen assay was similar to that described for the 
androgen assay (see section 2.1.1), except that an appropriate concentration of 
OHT (2.5x1 0-9 M - sufficient to give a sub-maximal response) was added to the 
medium, and phthalates were serially diluted from 10-2 M. A chemical was 
considered to be anti-androgenic if its presence inhibited the colour change 
induced by OHT. 
3.2.2 In vitro assays using mammalian breast cancer 
cell lines 
The phthalates used in these experiments were those obtained from Greyhound 
Chemservice. E2 was also of the same stock as that used in the recombinant 
yeast assay, thus making it possible to qualitatively compare the potencies of the 
phthalates relative to E2 in the different assay types. 
A detailed description of the method used can be found in section 2.1.2. 
3.2.3 Assessment of the estrogenic activity of BBP in 
vivo 
Since SSP was the most potent estrogenic phthalate in vitro, it was this particular 
phthalate which was chosen to be tested in an in vivo assay, using pair-breeding 
fathead minnows. The males of this species have distinct secondary sex 
characteristics, as can be observed in figure 3.3, which are thought to be 
androgen dependent. 
3.2.3.1 Experimental design 
Adult fathead minnows were supplied by AstraZeneca Ltd., Srixham, UK, and 
were exposed to SSP at a nominal concentration of 100 J,tg/L, for a period of 3 
weeks. The effect of the chemical exposure on their spawning frequency, total 
number of eggs spawned, and plasma vitellogenin was assessed. 4-NP, also at 
a nominal concentration of 100 J,tg/L, was assessed for its effect on these 
reproductive parameters in the same experiment. This chemical was used 
because it is a known endocrine disrupting chemical. For this experiment, SSP 
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Figure 3.3 
Adult male and female fathead minnows. Note that the male can be 
distinguished from the female by its larger body size together with its darker, 
stripy appearance, and characteristic fatpad which covers the top of the head 
and extends back over the dorsal area of the fish. The male appears to be 
guarding its territory - the spawning substrate (in this case a curved piece of 
plastic, to which eggs are attached). 
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was obtained from Greyhound Chemicals, and was certified as 98% pure; 4-NP 
(mixed isomers, 99% pure) was purchased from ACROS Organics, Leicester, UK. 
A flow-through system was used in the study; tank water was replenished at a 
rate of 30 Uhr. Chemicals were dosed (using methanol as a carrier solvent) into 
mixing vessels, from stock solutions of 0.5 gil, at a rate of 0.1 ml/min, prior to 
being dispensed into the tanks holding the fish. The chemicals flowed through 
the tanks for 10 days before any fish were added to the tanks, in order to allow 
the entire system to equilibrate. For each treatment, 4 pairs of fish were exposed, 
with 2 pairs of fish in each 30 litre tank, separated by a stainless steel grid. 
Fathead minnows are relatively straightforward to work with when measurements 
of fecundity are required, since they stick their eggs directly onto a substrate 
which can be removed from the tank for egg collection. Eggs were collected and 
counted each day, for a 3 week period prior to exposure ("pre"), followed by a 3 
week exposure period ("post"). At the end of the treatment, all fish were 
anaesthetised using MS-222 (Sigma, Poole, UK). The weights and lengths of 
the individual fish were recorded, and photographs were taken as a record of the 
secondary sex characteristics of the male of each pair. Blood samples were 
taken from the caudal sinus using 0.5 ml, 27G heparinised insulin needles, and 
centrifuged for 10 minutes at 14,000 rpm, the plasma was drawn off and stored at 
-20°C. Plasma vitellogenin concentrations were ascertained using a carp 
vitellogenin ELISA (Tyler et ai, 1996, 1999) previously validated for use in the 
measurement of vitellogenin in the fathead minnow. 
3.2.3.2 Chemical analysiS 
Water samples were taken from the treatment tanks, and from the stock bottles 
supplying each tank, after the 10 day equilibration period, prior to transferring the 
fish into the tanks. Samples were acidified with 2 ml HCI/L, and stored in the 
dark at 4°C. Aliquots of 100 ml were extracted onto 100 mg C18 Sep-Pak 
cartridges (Waters Ltd., Watford, UK), followed by elution with 2 ml methanol. 
The resulting eluent was reduced to approximately 0.2 ml under vacuum, and 
diluted with 0.2 ml water (pH 4.0); 0.2 ml of this sample was injected onto an 
HPLC. BBP and 4-NP were quantified by reverse phase HPLC, using a 5 Jlm 
C18 column (4.6x150 mm; Waters Nova-Pak, MA, USA). Gradient elution was 
carried out at 1 ml/min from methanol/water/acetic acid (70:29.9:0.1, 10 mins) to 
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100% methanol (20 mins). The detection instrument used was a photodiode 
array detector (Waters, MA, USA). Analyses of the tank water alone, or solvent 
treated tank water, were run to check for interference, and assess whether there 
was any background contamination of the water samples with either BBP or 4-
NP. The limits of detection for BBP and 4-NP were 0.05 Ilg/L and 0.1 Ilg/L, 
respectively. 
3.2.3.3 Assessment of estrogenicity of the tank water 
Water samples were collected as described above, preserved with 10 ml, 38% 
formaldehyde/L, and stored at 4°C in darkness prior to extraction. For samples 
containing nominal concentrations of 100 Ilg 4-NP/L, 100 ml aliquots of water 
were extracted; for all other samples (BBP dosed tanks, control tanks) 500 ml 
aliquots were extracted. The extraction procedure used is described in section 
2.5.2. Estrogenicity of the samples was determined using the recombinant yeast 
assay (2.1.1). Distilled water samples were spiked with BBP and 4-NP to give 
concentrations of 100 Ilg/L, and these were extracted using the same method. 
3.2.3.4 Statistical analyses 
Data were log-transformed where necessary, and analysed using Statview and 
SuperANOVA (Abacus Concepts Inc., Berkeley, CA). Differences between 
plasma vitellogenin concentrations of fathead minnows exposed to BBP and 4-
NP were determined using one-way ANOVA, followed by Scheffe's post-hoc test. 
Differences in number of eggs spawned by fish exposed to BBP and 4-NP were 
determined using one-way ANOVA, followed by Fischer's PLSD. 
3.3 RESULTS 
3.3.1 Estrogenic activity of phthalates in a recombinant 
yeast assay 
The estrogenic activities of the major volume usage phthalates (those exceeding 
20 000 tonnes/annum in Europe) in a yeast assay are shown in figure 3.4. Of , 
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Figure 3.4 
The estrogenic activity in the yeast assay of the phthalate esters used in 
large volumes (>20,000 tonnes/annum). Yeast cells were incubated 
with BBP, DBP, DIBP, DEHP, and DIDP at concentrations from 10-3 
M to 5x10-7 M. DINP i represents an inactive sample of this chemical, 
whereas DINP ii was a sample of this phthalate which induced 
B-galactosidase production to a slightly greater extent than the control, in 
a dose-related fashion. The results obtained from the inactive chemicals 
(DEHP, DIDP, DINPi) cannot be distinguished individually, because 
they overlie each other on the baseline, illustrating the lack of response 
observed when these chemicals were tested in the assay. 
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these six major volume use phthalates, three possessed estrogenic activity (SSP, 
DBP and DIBP), two did not (DEHP and DIDP), and one (DINP) behaved 
unreproducibly in the assay. Note that the former three phthalates were the most 
active of all those tested, with the latter three being the most extensively used in 
industry (see table 3.1). Two dose-response curves were obtained for DINP, due 
to the slightly non-reproducible behaviour of this chemical in this yeast assay. 
The line labelled DINP ii shows the mean response of two standard curves in 
which a detectable increase in B-galactosidase production was observed. This 
pattern was reproduced in three separate assays, but differed in a further three, 
where DINP appeared completely inactive (DINP i). 
The phthalates of relatively low or negligible use in Europe (table 3.2) were 
assessed for estrogenic activity using the yeast assay only. Relatively few of 
these (five in total) possessed any estrogenic activity; all others were inactive, 
even at the highest concentration tested (10-3 M) (figures 3.5, 3.6). The results 
obtained from the five estrogenic phthalates are illustrated in figure 3.5. Of these, 
only two (DEP and DTDP) are used commercially in Europe. 
All of the phthalates which showed activity were very weak estrogens. The most 
potent, BBP, was approximately one million-fold less potent than E2, making it 
considerably less potent than other environmental estrogens such as bisphenol-
A and 4-NP (approximately 10,000 and 9000-fold less potent than E2, 
respectively; Beresford et ai, 2000). When chemicals are so weakly estrogenic, it 
is entirely feasible that it is not the chemical (in this case the phthalate) itself 
which is intrinsically estrogenic, but rather that an impurity in the chemical is 
estrogenic. Thus, before labelling a chemical as a weak estrogen, it is necessary 
to exclude the possibility that the chemical is contaminated with an estrogenic 
impurity. One way to address this issue is to test a number of preparations, of 
different origin, of each phthalate possessing estrogenic activity. If all 
preparations of a phthalate possess the same degree of estrogenic activity, then 
it is likely that that particular phthalate is intrinsically active, whereas if the 
different preparations of a phthalate possess considerably different potencies, 
then it is likely that the phthalate itself is not estrogenic, but that some 
preparations contain varying proportions of one or more contaminants which are 
estrogenic. 
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Figure 3.5 
The estrogenic activity of commercially available phthalates and those of 
negligible use which are active in a yeast assay. DEP and DTDP are 
phthalates which are used commercially in Europe, albeit at volumes less 
than 20,000 tonnes/annum. DPhP, BCHP, and IHBP also showed 
dose-related estrogenic activity when tested at concentrations ranging from 
10 -3 M to 5xlO-7 M. These latter three are of negligible commercial usage. 
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Figure 3.6 
This figure portrays the lack of estrogenic activity obsenTed in a yeast 
assay when the cells were incubated with certain phthalates. These 
were DHP, DIHP, DMP, and DUP, and were all serially diluted from 
10 -3M. The results obtained from these phthalates cannot be 
individually distiguished, due to the fact that they overlie each other on 
the figure, indicating the lack of deviance from the baseline_ 
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In order to assess this possibility - that estrogenic contaminants might be present 
in some phthalates - commercial preparations of all the major volume usage 
phthalates, including DTDP and DEP, were assessed for estrogenic activity, and 
their potencies compared to that of their respective analytical standards (data not 
shown). With one exception, no differences were observed; the estrogenic 
activities of the commercial preparations were equivalent to those of their 
respective analytical standards. However, contrary to the analytical standard, the 
commercial preparation of DTDP failed to produce a response, even when 
present at 10-3 M. Both samples of DTDP were subsequently analysed by Ge-
MS. The analytical standard (the active sample) was found to contain 0.5% of 
the ortho-isomer of bisphenol-A. The inactive preparation of DTDP was not 
contaminated with this chemical. A sample of o,p'-bisphenol-A was then 
obtained, and its response in this yeast assay compared with that of the active 
DTDP sample. Figure 3.7 shows that o,p'-bisphenol-A was about 100 times 
more potent than the active sample of DTDP. Therefore, the presence of this 
chemical at just 0.5% in the DTDP sample would produce a response 
approximately equivalent to that seen. Thus, it is likely that this chemical (O,pl-
bisphenol-A) was responsible for the weak activity observed in this phthalate 
sample; hence, DTDP is not estrogenic. 
The results shown in figures 3.4 and 3.5 show that most of the active phthalates 
were unable to produce a maximal response in the yeast assay; only DTDP did 
so, and this was not due to the intrinsic activity of DTDP itself. For example, the 
response to BBP (the most estrogenic phthalate) reached a plateau at 
approximately 50% of the maximum response achieved with E2. To determine 
whether this means that most of the phthalates are only partial estrogen agonists, 
or whether other explanations account for the sub-maximal responses observed, 
a yeast assay of BBP was incubated for longer than usual, and the response 
monitored daily. The results (figure 3.8) show that on day 4 (the usual incubation 
time for our yeast assays), BBP produced a shallow dose-response curve. 
However, by day 6, the response was greater, and by day 13, the highest 
concentration of BBP had produced a near-maximal response. Note also that, 
whereas the dose-response curve to E2 moved approximately 4-fold to the left 
between days 4 and 13 (Le. the yeast assay became more sensitive), that for 
BBP moved considerably further. Thus, the potency of BBP increased somewhat 
with time. 
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Figure 3.7 
The activity of bisphenol-A (rows A and B), o,p' -bisphenol-A (rows D and E), and 
DTDP (rows G and H) in a recombinant yeast assay. Bisphenol-A and the ortho-
para isomer of this chemical were serially diluted (left to right) from 10-5 M. DTDP 
was serially diluted from 10-3 M. Rows C and F are controls; 10 jtl of ethanol (the 
carrier) was added to each of these wells. 
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Figure 3.8 
Development of the response to BBP over time in the yeast estrogen 
assay. 
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The phthalate metabolites tested included derivatives of the most abundant 
phthalate, DEHP, namely MEHP, and metabolites V, VI, and IX (Dirven et ai, 
1993); MBzP and MBP, these being primary metabolites of the most estrogenic 
phthalate, BBP, and MBP is also the primary metabolite of DBP and DIBP; MHP, 
MnOP, and MPeP. All were serially diluted from 10-3 M to 4.8x1 0-7 M, and none 
showed any signs of estrogenic activity in the yeast screen (data not shown). 
Table 3.3 summarises the relative potencies and the magnitude of the responses 
(compared to E2) of all phthalates that were active in the yeast screen .. 
CHEMICAL Approximate % Maximum 
(name & abbr.) Potency Response 
17B-Estradiol 
E2 1 100 
Diethyl phthalate 
DEP 0.0000005 30 
Dibutyl phthalate 
DBP 0.0000001 35 
Diisobutyl phthalate 
DIBP 0.0000001 30 
Butyl cyclohexyl phthalate 
BCHP Not determined 20 
Butyl benzyl phthalate 
BBP 0.000001 50 
Diphenyl phthalate 
DPhP Not determined 10 
Isohexylbenzyl phthalate 
IHBP Not determined 20 
Diisononyl phthalate 
DINP Not determined 15 
Ditridecyl phthalate 
DTDP 0.0000001 95 
Table 3.3 
The potencies of the phthalates which were active in the recombinant yeast 
assay. These were calculated from data obtained on day 6 of the assay. Longer 
incubation times can increase the relative maximum response. Thus, the values 
shown here apply only to a specific set of conditions. Potencies were calculated 
at 25% of the maximum response (in some cases, no potency could be 
calculated because the maximum response did not reach 25% of that produced 
by E2). All data shown here were obtained using analytical standards. 
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3.3.2 Estrogenic activity of phthalates assessed using 
mammalian breast cancer cell lines 
To assess whether the estrogenic responses observed in the yeast assay were 
reproducible in other estrogen assays, active phthalates (plus the major volume 
use phthalates DEHP and DIDP) were also tested for their abilities to stimulate 
proliferation of ZR-75 and MCF-7 cells. The results from these assays (figures 
3.9 and 3.10), which are based on human breast cancer cell lines, are mostly 
comparable to those obtained from the yeast assay. However, DEP and DTDP 
failed to induce proliferation of ZR-75 cells at 10-5 , 10-6 or 10-7 M (figure 3.9a), 
whereas they had been active in the yeast assay, albeit at higher concentrations 
only. Using the ZR-75 cells, DINP at 10-5,10-6, and 10-7 M induced proliferation to 
a significantly greater extent than the control (figure 3.9b), a result which is in 
contrast to our findings for this chemical using the yeast screen. Growth curves 
for all estrogenic phthalates (i.e. those active in the yeast assay), and for DEHP 
and DIDP, were obtained using MCF-7 cells. The results (figure 3.10) showed 
that BBP was considerably more mitogenic than any of the other phthalates. 
DTDP, DIBP, and DBP were approximately equivalent in activity, and all the other 
phthalates tested showed relatively little, if any, activity. All these results are 
consistent with those obtained using the yeast assay. 
3.3.3 Anti-androgenic activity of phthalates in a 
recombinant yeast assay 
Figure 3.11 shows that the major metabolites of DEHP (MEHP), DBP (MBP), and 
BBP (MBP and MBzP), can block the binding of dihydrotestosterone (DHT) to the 
androgen receptor, i.e. that these phthalate metabolites are acting in an anti-
androgenic manner. Also assessed for anti-androgenic activity were the 
remaining high volume use phthalates DEHP, DINP, DIDP, DBP, and DIBP, 
together with DEP which had been found to be weakly estrogenic in the yeast 
estrogen assay. All of these phthalates showed some evidence of anti-
androgenic activity at the highest concentrations tested (> 10-3 M); all of them, with 
the exception of DEP, were less potent as anti-androgens than BBP (data not 
shown). 
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Figure 3.9 
The proliferation of ZR-75 cells incubated with various phthalates is illustrated 
(data obtained from three separate assays). Cell numbers which were 
significantly greater than the control are denoted by * (p<O.05), ** (p<O.Ol), 
*** (p<O.OOl). 
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Figure 3.10 
This figure depicts the proliferation of MCF-7 cells incubated 
wi th 10-8 M 17B-estradi 01, 0.1 % ethanol (control), or 10-5 M of 
DEHP, DIDP, DIBP, DINP, BBP, DBP, DEP, DTDP, and 
monitored over a time period of 12 days. 
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Figure 3.11 
The anti-androgenic activities of BBP, MBP, MBzP, and MEHP. 
Each chemical was serially diluted from 10-2 M, and compared to the 
activity of the clinical anti-androgen flutamide, which was serially 
diluted from 10-3 M. Anti-androgenic activity was detected using a 
recombinant yeast-based assay. The figure illustrates the ability of 
these chemicals to block the normal androgenic response to DHT. 
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3.3.4 Assessment of the estrogenic activity of BBP in 
vivo in fathead minnows 
3.3.4.1 Chemistry and estrogenic activity of the tank water 
samples 
The mean actual concentration of BBP measured in the tank water samples was 
75.5 Jlg/L (see table 3.4). Note, however, that this was the concentration 
measured before the fish were transferred to the tanks (water samples were only 
collected for chemical analysis at one timepoint - this being prior to the 
introduction of the fish). It is likely that the actual concentration of BBP in the 
water would have decreased following deployment of the fish, due to absorption 
by the fish, and degradation processes. It is also true, however, that the stocking 
density was fairly low in these tanks (4 fish per 30 litre tank), and this factor, 
together with the rapid replenishment of dosed water (Le. a complete change of 
water in one hour), might lead us to expect that the drop in concentration due to 
the presence of the fish would not be especially pronounced. 
Treatment Nominal tank water Mean measured tank water 
concentration (ug/L) concentration (ua/L) 
Control 0 0 
Solvent Control 0 0 
Butylbenzyl phthalate 100 75.5 
4-nonylphenol 100 71 
Table 3.4 
Mean measured concentrations of BBP and 4-NP in the treatment tanks (n=2 
tanks) prior to the introduction of the fish. Note that the detection limits for BBP 
and 4-NP were 0.05 Jlg/L and 0.1 Jlg/L, respectively; the concentrations of BBP 
and 4-NP measured in the control tanks were below these detection limits. 
The data from the yeast estrogen assay performed on these samples are shown 
in figure 3.12. Water samples taken from the tanks dosed with BBP elicited a 
'partial' dose-response curve, which is characteristic of that observed with BBP in 
this (and other) assays (see section 3.3.1). This would suggest that the 
estrogenic activity observed is due to the presence of BBP in these samples. 
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Figure 3.12 
The estrogenic activities of the tank water samples compared with that of 
chemical standards. The water samples were concentrated during the 
extraction process (the BBP samples were concentrated x 2000, and the 
4-NP samples x 400), and the curves have been plotted according to 
their nominal concentration times the concentration factor (i.e. the 
nominal concentration of the final concentrated sample). This means 
that, were the actual concentrations equal to the nominal concentrations, 
the response curves should overlay those of the standard chemicals. 
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Clearly, this is not conclusive, but it is useful in cases such as these to be able to 
distinguish between chemicals with distinct behavioural patterns. Likewise, 4-NP 
exhibits a pattern known to us as 'creeping' in the yeast assay. This results in the 
blank wells to either side of the 4-NP standard curve also demonstrating a very 
clear estrogenic response. This phenomenon has been discussed in Beresford 
et al (2000). The water samples taken from the tanks dosed with 4-NP also 
exhibited this 'creeping' behaviour, thus suggesting that the chemical 
responsible for inducing estrogenic activity in the yeast assay was indeed 4-NP. 
Water samples from the control tanks showed no estrogenic activity (data not 
shown), indicating that there was no estrogenic contaminant inherent in the water 
supply. Since the water samples were concentrated during the extraction 
process (the BBP samples were concentrated 2000-fold, and the 4-NP samples 
400-fold), the curves in figure 3.12 have been plotted according to their nominal 
concentration multiplied by these concentration factors (i.e. the nominal 
concentration of the final concentrated sample). This means that, were the actual 
concentrations equal to the nominal concentrations, the response curves should 
overlay those of the appropriate standard curves. In actual fact, the curve 
obtained from the water samples dosed with 4-NP is displaced slightly to the right 
of the standard curve for 4-NP, implying that there is slightly less 4-NP in the 
sample than expected. The curve from the water sample dosed with BBP 
actually overlies that of the standard curve, implying that the concentration of 
BBP in the water sample equates with that of the nominal concentration. 
3.3.4.2 Plasma vitellogenin concentrations 
Vitellogenin concentrations of both male and female fish are depicted in figure 
3.13. This indicates a clear and significant increase in vitellogenin in the plasma 
of the male fish exposed to 100 Ilg 4-N P/L (the concentration increased about 
SOOO-fold). There was also a slight, but nonetheless significant, increase in 
vitellogenin concentration in the female fish exposed to the same treatment. 
Conversely, there was no increase in plasma vitellogenin (compared to the 
control) in either the males or the females exposed to 100 Ilg BBP/L. 
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Figure 3.13 
Vitellogenin concentrations in the plasma of mature fathead minnows 
exposed to 4-NP and BBP at 100 pg/L. 'F' denotes the female fish, 
and 'M' the males. Significant differences (p<O.05) are shown by 
an asterisk. 
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3.3.4.3 Fecundity 
The total number of eggs spawned by the fish in each treatment (expressed as a 
mean per pair of fish) is shown in figure 3.14. The number of eggs spawned in 
the pre-exposure period is compared to the number spawned during exposure 
('post') within each treatment. There was no effect on absolute fecundity of the 
fish exposed to 100 J,!g BBP/L. Exposure to 100 J,!g 4-NP/L reduced the number 
of eggs spawned significantly; indeed, the fish in these tanks almost ceased to 
spawn (after a period of seven days exposure, two of the four pairs did not spawn 
for the remainder of the study). 
3.4 DISCUSSION AND CONCLUSIONS 
The phthalates which have been studied here are used by industry in variable 
amounts, the greatest of which is for DEHP, at up to 500,000 tlannum in Western 
Europe. The world-wide production of another class of chemicals, the 
alkylphenol polyethoxylates, was 360,000 tlannum in the late eighties (Ahel et ai, 
1993), which puts into perspective the large scale usage of phthalate esters as 
industrial chemicals, and therefore their potential environmental importance. 
In terms of their estrogenic behaviour, it seems that those requiring further 
scrutiny include: a) the shorter chain phthalates, namely BBP, DBP, and DIBP, 
which are used by industry in smaller quantities (Table 3.1), but are more 
estrogenically active; and b) the longer chain phthalate DINP, which although 
extremely weakly estrogenic in vitro, is used in large quantities (up to 200,000 
tlannum in Europe). The estrogenic behaviour of the phthalates in these assays 
compares favourably to that previously reported. For example, the potency of 
BBP (approximately 1 million-fold less potent than estradiol in a yeast assay) was 
similar to that reported by Sonnenschein et al (1995) and Soto et al (1995) in the 
E-Screen assay (3 million-fold less potent than estradiol), and the relative 
potencies of the phthalates reported to be estrogenic by Jobling et al (1995) 
corresponds to that observed in the yeast assay employed here (BBP>DBP). It 
must also be noted that, generally speaking, the activities of the phthalates in the 
recombinant yeast assay were reproduced in the assays based on mammalian 
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Figure 3.14 
Total number of eggs spawned by fathead minnows exposed to BBP 
and 4-NP at 100 pg/L. Data are shown for a 3 week pre-exposure period, 
follwed by a 3 week exposure period. * denotes a significant difference 
(p<O.05) between the total number of eggs spawned in the pre and post 
experimental periods within that treatment group. 
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cells, thus inferring that these are real estrogenic effects, and not artefactual. 
There were occasional discrepancies between the results of these assays; for 
example, DTDP and DEP were not found to be mitogenic in the ZR-75 cell line, 
but had shown Slight mitogenic activity in the MCF-7 assay, and produced a 
positive response in the recombinant yeast assay. The yeast cells are more 
robust than mammalian cells, and so could be exposed to higher concentrations 
of phthalates with no adverse effects, hence accounting for the observation of 
activity at the higher concentrations applied in the yeast assay. The reasons for 
any discrepancies between the two mammalian assays are unclear, but may be 
a result of the enhanced proliferation of the MCF-7 cell line in the presence of 
growth factors (the identity of which are not known) as well as estrogens, 
compared to the ZR-75 cell line, in which proliferation is more estrogen specific. 
All active chemicals, however potent, are said to be active because they cause a 
response above that of the baseline. However, for all active phthalates, only a 
partial dose-response was observed after the usual incubation time used in the 
yeast assay. For example, for DINP, the most used of all the active phthalates, 
the maximum response was just 15 percent of the maximum response obtained 
with E2. A possible explanation for results such as these, which suggest partial 
agonistic behaviour of the phthalates, is that these chemicals were not fully 
solubilised in the water-based medium employed in these assays. This is a 
situation frequently encountered when applying highly organic compounds to in 
vitro assays, and is an entirely feasible explanation since, generally speaking, 
the solubility values for phthalates are lower than the concentrations used in 
these trials. Thus it is plausible that some of the phthalates tested are actually 
more potent than appears to be the case. However, it must be noted that the test 
chemicals were added to the medium of the mammalian cell assays in ethanol, 
thus leading to greater homogeneity throughout, and still only a partial response 
was observed. Conversely, contamination of a chemical with an estrogenic 
compound can imply a weak estrogenicity of the substance in question, when it is 
in fact the contaminant that is generating the observed response, and the 
chemical under investigation is not estrogenically active. This phenomenon was 
detected in the case of DTDP, where the weakly estrogenic preparation was 
found to be contaminated with the ortho-isomer of bisphenol-A. Hence, caution 
must be applied when labelling a chemical a weak estrogen, particularly if the 
chemical is not pure (which is usually the case, especially with industrial 
chemicals) . 
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Siom et al (1998) reported that DEHP was estrogenically active, and as strongly 
so as 4-NP (a chemical widely accepted to be a weak xenoestrogen), in an in 
vitro MCF-7 cell proliferation assay. This result was unusual in that, in previous 
reports where DEHP has been found to induce a response greater than that of 
the control, this has been extremely slight, so much so that it has been equivocal. 
Further, any phthalates which have been tested in any in vitro assay in which 4-
NP has also been included have been found to be far less potent than this 
"model" xenoestrogen (80to et ai, 1995; Petit et ai, 1997; Coldham et ai, 1997; 
Solger et ai, 1998). It is possible that Siom et ails finding of appreciable 
estrogenicity of DEHP is a real result, but it is also conceivable that this response 
was due to some form of contamination of the chemical or equipment used. 
If a chemical exhibits only weak estrogenic activity in vitro, it does not necessarily 
follow that the effect of the same chemical, when applied to a whole organism, 
will be insignificant. Unfortunately, results of the nature obtained here cannot be 
directly extrapolated to an in vivo situation. Presently, few phthalates have been 
assessed for their estrogenic activity in vivo, and it will be necessary to test more 
of these chemicals in vivo, via different routes of exposure, before reaching 
conclusions. Though in vitro assays give us an idea of the potential strength of a 
chemical as a xenoestrogen, they cannot simulate changes to the chemical 
within an organism, or replicate differences in the physiological systems of 
individual organisms, which may influence the potency and/or bioavailability of 
the chemical. Metabolic processes will vary greatly depending on the route of 
uptake, and on the characteristics of both the chemical and the organism 
concerned. 
The in vivo results discussed in this chapter suggest that SSP, at a concentration 
far higher than is generally found in the aquatic environment, is not estrogenic to 
fathead minnows. In addition, no effects of SSP on reproductive capability (the 
number of eggs produced by a spawning pair of fish) were observed. Note, 
however, that this study was performed over a relatively short time period (3 
weeks), and that only adult fish were investigated, and not the offspring of 
exposed adults. 
In general, there are minimal data available relating to the possible estrogenicity 
of phthalates in the aquatic environment. The production of the egg-yolk protein, 
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vitellogenin, is an estrogen-dependent process, and therefore can be used as a 
biomarker for estrogen exposure of wild and aquaria fish (Sumpter and Jobling, 
1995). This applies particularly to males, or immature females, where basal 
vitellogenin concentrations are extremely low. Christiansen et al (1998) injected 
high doses of DBP and BBP into immature rainbow trout; DBP did not induce 
vitellogenin production in any of the treated fish, whereas BBP induced a very 
weak (3-fold) increase in vitellogenin concentration. It is not entirely clear what 
relevance this route of exposure has to a real environmental situation, but this 
was intended purely as a preliminary study to assess the activity of a chemical in 
a worst case scenario, presumably to be succeeded by a more realistic dosing 
regime. However, follow-up data have not yet been reported. 
Knudsen et al (1998) monitored two alternative endpoints in juvenile rainbow 
trout injected with BBP at concentrations of 5 and 50 mg/kg, namely the 
upregulation of the ER in the liver and the induction of hepatic zona radiata 
proteins (Zrp). This latter protein is more sensitive to estrogens than is 
vitellogenin, according to Arukwe et al (1997). BBP had no significant effect on 
the ER binding capacity at either dose, and actually decreased Zrp levels. The 
reason for the decrease in Zrp levels is not known, but it was conjectured to be 
some kind of antagonistic effect at the receptor level. Whatever the explanation, 
there was no evidence of any estrogenic activity of BBP. 
Thus, although there are very little data available on which to base a conclusion, 
it seems unlikely that phthalates will demonstrate any significant estrogenic 
effects in vivo in fish, especially at environmentally-relevant concentrations. 
Nevertheless, there is a need for a few multi-generation studies, using at least 
one fish species and one invertebrate species, and a variety of concentrations of 
the test phthalate, before robust conclusions can be drawn. 
Despite phthalates not eliciting an estrogen-specific response in mammalian 
species in vivo, it is nonetheless clear that they are capable of disrupting the 
reproductive development in utero of young mammals (Ema et ai, 1998; Imajima 
et ai, 1997; Piersma et ai, 1995; Wine et ai, 1997). The question therefore arises, 
"what are the mechanisms behind this activity?" Is it possible that we have been 
looking in the wrong direction, and that what is actually happening is that the 
phthalates are having an inhibitory effect on the androgen receptor? This is 
without doubt an area which needs to be investigated in greater depth, 
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particularly given that the majority of adverse effects observed following in vivo 
exposure of mammalian species occur in the male offspring. As well as 
investigating this issue further in mammalian species, there is a need to monitor 
specific anti-androgenic endpoints in aquatic organisms. However, presently 
there is a paucity of suitable endpoints, especially in lower vertebrates and 
invertebrates. Thus, for example, despite having an excellent indicator of 
estrogen action in oviparous vertebrates such as fish and amphibians 
(vitellogenin), there are presently no comparable indicators of either androgenic 
or anti-androgenic activity. Thus, even if phthalates (or any other chemicals) did 
have androgenic and/or anti-androgenic activity in vivo, this would be very 
difficult to detect in many species, especially those, such as fish, used in aquatic 
toxicity tests. 
Some of the primary metabolites of the phthalates have been found in this study 
to possess anti-androgenic characteristics. These are potentially highly 
significant data, when it is considered that the weak estrogeniC activity of 
phthalates is often thought of as not constituting a risk, due to their rapid 
metabolism to the estrogenically inactive monoesters in vivo, and also in the 
environment. These data may in part explain the results of an in vivo study, 
describing the behaviour of DBP as similar to that of the clinical anti-androgen, 
flutamide (Mylchreest et ai, 1998). In that study, Sprague-Dawley rats were orally 
administered high doses (250, 500, and 750 mg/kg/day) throughout gestation 
and lactation, until postnatal day 20. The spectrum of adverse reproductive 
effects in the male offspring included decreased anogenital distance, malformed 
epididymides, testicular atrophy, hypospadias, ectopiC or absent testes, absent 
prostate gland and seminal vesicles, and diminished size of testes and seminal 
vesicles. In contrast, estrogen dependent endpoints in female offspring, such as 
vaginal opening and estrous cyclicity, were not affected. Figure 3.15 illustrates 
data from some of the parameters measured in that study. 
A subsequent study by the same authors (Mylchreest et ai, 1999) covered a 
shorter exposure period which encompassed gestation days 12 to 21; that is, the 
period during which androgen-dependent prenatal male reproductive tract 
development occurs. Despite widespread adverse reproductive effects in 
offspring of DBP-treated rats, many of which were common to both DBP and 
flutamide, there were some which were distinct to either one or the other of the 
chemicals. These included a high incidence of prostate agenesis (non-
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Figure 3.15 
In vivo anti-androgenic effects of DBP. The data were taken from 
Mylchreest et al (1998), and show adverse effects of 250, 500, and 750 
mg DBP/kglday on androgen regulated endpoints in rats. The DBP was 
given to pregnant rats throughout gestation and lactation, through to 
postnatal day 20, and organ weights recorded from the male offspring. 
* indicates a significant difference from the control group (p<O.05). 
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development) in flutamide-exposed offspring compared to the incidence found in 
DBP treated rats, and the blocking of the inguinoscrotal descent of the testis by 
flutamide, compared to that of the transabdominal descent caused by DBP. The 
authors concluded that exposure of fetuses to DBP during the sensitive window 
of gestation (days 12-21, covering the period of sexual differentiation in the rat), 
can lead to severe reproductive disruption in male offspring. Although the effects 
seen were considered to be mediated via an androgen-regulated pathway, it was 
hypothesised that the mechanism did not involve direct interaction with the 
androgen receptor, since the behaviour of DBP differed from that of flutamide in 
some ways. This interpretation was supported by the results of Gray et al (1998), 
who found DBP and MBP not to have an agonistic interaction with the AR in 
receptor binding and transcriptional activation assays. However, the data shown 
in figure 3.11 suggests that MBP - the metabolite of DBP likely to be found in the 
exposed rats - does have a receptor mediated antagonistic mechanism. 
These results, demonstrating an anti-androgenic action of DBP in vivo, are very 
important for a number of reasons. Firstly, they demonstrate that, despite several 
decades of research on DBP, unexpected, and important, effects can still be 
discovered. Secondly, that despite the failure to observe estrogenic effects in 
females (the research was undertaken originally to see if the estrogenic effects 
observed in vitro were also manifest in vivo), effects indicative of another type of 
endocrine activity, namely anti-androgenicity, were observed in males. Thirdly, 
that the timing of exposure is all important; exposure produces effects only if it 
occurs during the relatively brief period of sexual differentiation. Subsequent 
research can now involve lower doses, to determine if there is a real risk at 
realistic levels of exposure. Such research can obviously only be conducted 
using in vivo experimental designs. 
Another difficulty in estimating the environmental hazard posed by phthalate 
esters is the lack of data documenting the degree of exposure of humans, or 
wildlife, to these chemicals. The fact that phthalates are used in a wide variety of 
extensively employed goods is indisputable. It is also known that they can exude 
from these products; for example, DBP has been found to leach from dentures 
(Lygre et ai, 1993), as has DINP from milk tubing (Wildbrett, 1973). Furtmann 
(1996) has suggested that the main source of phthalates are the consumer 
products themselves, and that there is some justification in the inference that 
following dumping or incineration of these products, there are considerable 
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phthalate emissions into the environment. The estimated total loss of phthalate 
esters in Western Europe has been put at 7740 tlannum, or approximately 1 % of 
total consumption (ECPI, 1996). However, the use of such data in the analysis of 
environmental hazard assessment for individual chemicals is problematic, since 
the data are generalised, and estimates refer to total phthalates. 
Sy far the most frequently reported phthalate, and that found at the highest 
concentrations in the environment, is DEHP. This is to be expected, considering 
its high usage and greater likelihood of persistence relative to the shorter chain 
phthalates. For this reason, one would also expect DIDP and DINP to be 
apparent in environmental samples, but reports concerning these latter 
phthalates are sparse. Other phthalates which have been regularly documented 
in food (MAFF, 1990; Page and Lacroix, 1995), air (Thuren and Larsson, 1990; 
Giam et ai, 1980), sediments (Furtmann, 1996; Parkman and Remberger, 1995), 
and river water (Sheldon and Hites, 1978; Pirie et ai, 1996) include the lower 
molecular weight phthalates, such as DMP, DEP, DSP and SSP. These are less 
stable as plasticisers, and therefore liable to migrate from a polymer matrix, 
particularly when this material is subjected to elevated temperature or 
surrounded by a lipophilic medium. For this reason, despite lower consumption 
of these phthalates compared to the higher molecular weight species, it is 
perhaps not surprising that they are commonly detected, albeit at very low 
concentrations, in environmental samples. The solubility and environmental 
persistence of individual phthalates is somewhat dependent upon the chain 
length of the phthalate concerned. For a more detailed discussion of the 
behaviour of phthalates in, particularly, the aquatic environment, see Furtmann, 
1996. 
Overall, the concentrations at which adverse effects have been reported to occur 
have been far higher than those which we would expect organisms to be 
exposed to in a real environment. It seems unlikely that the low levels of 
phthalates to which humans are exposed are capable of causing the trends in 
adverse reproductive health of males over the past few decades, such as 
decreased sperm counts (if true), and increased incidences of testicular cancer, 
cryptorchidism, and hypospadias. However, it is theoretically possible that they 
may be a contributory factor. The biggest problem in this area is that humans, 
and wildlife, are exposed simultaneously to complex mixtures of chemicals, 
which might (or might not) have some net adverse effect, whereas almost all 
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toxicology is based upon the testing of one chemical at a time on a very limited 
range of species. These chemicals could interact (to produce an effect) in 
various ways, ranging from one antagonising another, thereby reducing the 
anticipated effect, through to one synergizing with another, thereby increasing 
the anticipated effect. The phenomenon of synergism, though widely speculated 
upon, has not yet been proven to occur, either in vitro or in vivo (at least in 
research on endocrine disruption), but it is accepted that environmental 
estrogens at least can have additive activity when assayed together. For 
example, Jobling et al (1995) found BBP and DBP to have additive agonistic 
effects when in the presence of E2 in a transcriptional activation assay. This 
complicated, but very important, area of research is only just beginning. 
Another factor influencing the occurrence of phthalates in the environment is their 
potential for persisting, and accumulating, in organic matrices. This would be 
expected to be high, since they are hydrophobic chemicals, and thus it might be 
possible to predict their environmental fate pattern based on that of other man-
made organic chemicals. For example the polychlorinated biphenyls (PCBs) 
(Alcock et ai, 1994), and 4-nonylphenol (Warhurst, 1995), bioaccumulate in 
organisms which are exposed to these chemicals over a period of time, and 
biomagnify through the food chain. However, phthalates appear to be more 
readily metabolised than these persistent chemicals, particularly by enzymes in 
the gut (Albro and Lavenhar, 1989) and in sewage treatment works, although 
their rate of degradation does appear to be influenced by the length of their side 
chain (Shelton et ai, 1984; O'Grady et ai, 1985). It is not known whether the 
yeast strain employed in my assays is capable of metabolising complex organic 
chemicals, although methoxychlor has shown a positive response in the 
recombinant yeast screen (Ashby et ai, 1997b), and it has been reported that this 
chemical must be metabolised before it becomes estrogenically active 
(Ousterhout et ai, 1981), thus suggesting the yeast strain is capable of 
metabolizing certain organic chemicals. A small number of phthalate metabolites 
were tested in the recombinant yeast estrogen assay. These included monobutyl 
phthalate (the primary metabolite of DBP and DIBP), and monobenzyl phthalate 
(this, or monobutyl phthalate, would be the primary metabolite of BBP). All 
metabolites tested were inactive in this assay, suggesting that it is the parent 
compound exhibiting estrogenic behaviour. 
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It is conceivable that the route of exposure of an organism to the phthalates is an 
important parameter when considering metabolism of these chemicals in vivo. It 
seems probable that they are readily metabolised in the gut, such that oral 
exposure would not lead to accumulation of high concentrations of these 
chemicals. However, there are few data available on the metabolism of this 
group of chemicals following inhalation or dermal exposure. It is perhaps 
necessary to investigate the fate of phthalates within an organism following 
administration via these routes, judging by the presence of these chemicals in a 
wide array of contact media. In addition, uptake via the gills, and hence directly 
into the blood system, as presumably occurs in fish, may elicit responses that 
other routes of exposure would not. 
CONCLUSIONS 
In summary, a small number of commercially available phthalate esters (SSP, 
DISP, DSP, DEP, DINP) are capable of acting as extremely weak estrogens in 
vitro. The relevance of this to their environmental impact cannot be directly 
estimated yet, partly because comprehensive data concerning the environmental 
fate and behaviour of these individual phthalates are not available, and partly 
due to the impracticalities involved with extrapolating in vitro data to a whole 
animal situation. The phthalate most widely used by the plastic industry, and that 
reported on with greatest frequency, is DEHP. This phthalate did not show 
estrogenic activity in the assays employed in this chapter. Laboratory 
biodegradation studies, particularly of the shorter chain phthalates (that is, those 
which are the more potent xenoestrogens), might imply that concentrations in the 
environment as a whole, and within an organism, would not reach values high 
enough to be of significant danger. Although the potential exists for the above 
mentioned chemicals to generate adverse effects when present within an 
organism, the concentrations, and the conditions of exposure, required to do so 
are unknown. Also note that the results of in vivo experiments, such as those 
reported by Sharpe et al (1995), and Wine et al (1997), may not be due solely to 
the weak estrogenic activities of the particular phthalates administered, but may 
involve other, and possibly more important, mechanisms of action. For example, 
DEHP has been recognised for many years to be a reproductive toxicant 
(Gangolli, 1982; Gray and Gangolli, 1986; Siddiqui and Srivastava, 1992; Davis 
et ai, 1994), yet this particular phthalate demonstrated no estrogenic behaviour in 
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the assays employed in this study. The potential of some of the phthalates, and 
their metabolites, to induce anti-androgenic effects has only recently come to 
light, and must also be taken into consideration. It may also transpire that it is not 
simply a matter of the response of a parent organism to the chemical concerned, 
whether exposure is acute or chronic, but that any effect may not be detected 
until subsequent generations. This possibility has been very clearly 
demonstrated by Wine et al (1997), who found that adverse reproductive effects 
induced by DBP in Sprague-Dawley rats were most pronounced in the second 
generation, although the mechanisms generating these responses are unknown. 
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